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ABSTRACT 
 
GABAergic Systems in a Model of Age-Related Cognitive Impairment.  
(May 2011) 
Candi Lynn LaSarge, B.S.; B.S., University of Washington; M.S., Texas A&M 
University 
Chair of Advisory Committee: Dr. Jennifer L Bizon 
 
With medical advancements extending the life span, age-related cognitive 
decline is a growing problem for the United States. A rat model of cognitive 
aging was used to investigate the GABAergic neurotransmitter system in relation 
to changes in learning and memory functions. Confocal stereology was used to 
determine the number of GABAergic and cholinergic projection neurons in the 
rostral basal forebrain of spatially characterized young and aged male F344 rats.  
The GABAergic system was then assessed as a potential target for improving 
age-related cognitive decline using an odor discrimination task sensitive to 
decline in aging.  
Performance of aged rats was impaired compared to young rats on the 
spatial version of the Morris water maze. Notably, a high degree of variability in 
individual abilities was observed among aged rats such that some aged rats 
performed on par with young (aged-unimpaired) and others performed outside 
the range of young, demonstrating impairment (aged-impaired). The number of 
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basal forebrain neurons expressing multiple immunomarkers for GABAergic 
septohippocampal projection cells was selectively increased in aged-impaired 
rats in comparison to both young and aged-unimpaired rats. Indeed, among 
aged rats, worse performance in the water maze was reliably associated with 
higher GABAergic cell number. The number of cholinergic neurons, quantified in 
adjacent sections did not differ as a function of chronological age or cognitive 
status. These data suggest that aging can dysregulate GABAergic systems in 
circuitry important for learning and memory and such alterations may contribute 
to age-related cognitive decline. 
To test whether the GABAergic system may be a viable target for treating 
age-related cognitive decline, a second cohort of young and aged rats was 
characterized in an odor discrimination task. Similar to aged rat water maze 
performance, some aged rats performed odor learning discrimination problems 
on par with the young cohort (i.e. aged-unimpaired) and some aged rats were 
impaired compared to young (i.e. aged-impaired). Using a within-subjects 
design, the GABA(B) antagonist, CGP 55845 completely ameliorated  odor 
discrimination learning deficits in aged-impaired rats in a dose-dependent 
manner. These data support the hypothesis that the GABAergic system should 
be a novel target for therapies aimed at treating age-related cognitive decline.  
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CHAPTER I 
INTRODUCTION: GABAERGIC SYSTEMS IN COGNITION AND AGING 
 
Advancements in medical sciences and technology have contributed to a 
significant increase in the human lifespan over the last half century, from 
approximately 68.2 years in 1950 to 77.9 years in 2007 (Xu et al., 2010). With 
more people living to advanced ages in the United States, the elderly population 
is expected to escalate from 35 million in 2000 to over 70 million by the year 
2030 (Federal Interagency Forum on Aging-Related Statistics, 2004). The ability 
to maintain cognitive function into advanced age is a major concern from both an 
individual and a public health perspective. Severe dementia resulting from 
pathological conditions such as Alzheimer’s disease (AD) will impact 7 – 8% of 
aged individuals and is the 6th leading cause of death in Americans; however, a 
much larger number of the elderly will experience cognitive decline that 
substantially impacts quality of life without the manifestation of age-related 
disease (Freedman et al., 2002; Xu et al., 2010). In order to prevent or 
pharmacologically target age-related cognitive decline, it is critical to thoroughly 
understand the neurobiological underpinnings of deficits in learning and memory 
at advanced ages.  
 
 
 
 
____________ 
This dissertation follows the style of Neuroscience. 
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Naturalistic variability in aging 
Although many people will experience a decline in cognitive function with 
advancing age, this decline is not an inevitable consequence of the aging 
process. The natural aging progression in humans shows substantial variability 
in the decline of mnemonic abilities such that some people begin to show 
impairments in their fourth decade while others perform on par with young adults 
past their seventieth year of life (Albert, 1993; Small, 2001; Bizon and Nicolle, 
2006).  Naturalistic rat models demonstrate a similar variability in cognitive 
performance at advanced ages, particularly in the domain of spatial reference 
memory. Some aged rats perform as well as young cohorts in tasks like the 
water maze, whereas others perform outside the range of young, demonstrating 
impairment (Gallagher et al., 1993; for review see LaSarge and Nicolle, 2009). 
Thus, not all aged rats show a decline in spatial learning performance, allowing 
for their reliable separation into two groups that from here on will be defined as 
“aged-unimpaired” and “aged-impaired” (LaSarge et al., 2007; Bizon et al., 
2009). Understanding the reasons that some aged rats maintain mnemonic 
function well into advanced ages while others are impaired can aid in 
understanding human age-related cognitive decline and help to determine new 
pharmacological therapies to halt or reverse cognitive deficits. 
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Age-related impairment in memory and olfaction  
Impairments associated with explicit memory (i.e. the ability to encode 
and recall information about people, places, and things) and olfactory function 
are among the earliest and most widely reported deficits associated with the 
aging process (Gabrieli, 1996; Freedman et al., 2002). A large amount of 
literature suggests that basal forebrain (BF) neurons that project to both MTL 
and olfactory bulb targets are vulnerable to changes with age, including death, 
and that these projections are important for cognition (Fischer et al., 1991; 
Mufson et al., 2002; Smith et al., 2004). It is now well-established that explicit/ 
spatial memory deficits can occur even in the absence of frank neural loss in 
medial temporal lobe structures (Rapp and Gallagher, 1996; Rapp et al., 2002; 
West et al., 2004; Shamy et al., 2006). Impairments in declarative memory tasks 
related to the medial temporal lobe (MTL), such as remembering spatial 
relationships and landmarks, are common in aged humans. Studies using 
Positron Emission Tomography (PET) and magnetic resonance imaging (MRI) 
show that the MTL is one of the brain areas most susceptible to age-related 
decline in function (Lipman, 1991; Jack et al., 1997; Small, 2001; Rosenzweig 
and Barnes, 2003; Raz, 2004) . Additionally, olfactory deficits have become 
recognized as an early indicator of cognitive decline in humans, and a decline in 
olfactory function is correlated with impairment in 19 cognitive batteries including 
explicit memory, working memory, and visuospatial ability (Eibenstein et al., 
2005; Wilson, 2006).  
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Septohippocampal anatomy 
The medial temporal lobe contains the hippocampal region, consisting of 
the hippocampal formation and parahippocampal region (for review of 
hippocampal anatomy see Witter and Amaral, 2004). The hippocampus forms a 
“C” shaped structure that extends from the septal nuclei of the BF rostrodorsally, 
over and behind the diencephalon, and caudoventrally in the temporal lobe. The 
parahippocampal region includes the entorhinal, perirhinal, and postrhinal 
cortices, located caudal and ventral to the other areas of the hippocampal 
formation. The entorhinal cortex (EC) that projects to all hippocampal subfields 
also has bidirectional communication with both perirhinal and postrhinal cortices 
which, in turn, have afferent and efferent projections to the neocortex, linking the 
hippocampus to broader circuitry in the brain (see Bizon and Nicolle, 2006). 
Projections from the cholinergic and γ-Aminobutyric acid containing 
(GABAergic) neurons in medial septum (MS) and Diagonal Band of Broca (DB) 
provide the major innervations from BF to the hippocampal region. MS/DB 
neurons project to hippocampus and some parahippocampal regions through 
multiple pathways that include the fimbria and dorsal fornix, which also contain 
reciprocal projections to the BF (Zaborszky et al., 1999; Butcher and Woolf, 
2004; Witter and Amaral, 2004). The fornix splits at the anterior commisure and 
the rostral extension innervates septal nuclei and other BF structures.  
The septohippocampal pathway is comprised of both cholinergic and 
GABAergic projection fibers that synapse on different target cells. Estimates 
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indicate that 30-50% of neurons from MS nuclei and 50-75% neurons from DB 
nuclei that innervate the hippocampus are cholinergic, with GABAergic neurons 
comprising a large portion of the remaining projection (Witter and Amaral, 2004). 
There are both excitatory (pyramidal cells) and inhibitory (GABAergic 
interneurons) neural targets for cholinergic neurons. Cholinergic projections 
commonly synapse on pyramidal neurons; however, cholinergic synapses have 
also been identified on other hippocampal neurons including parvalbumin 
(PARV) containing GABAergic basket cells (Semba, 2000). The role of the 
cholinergic neurons in cognition has been the focus of a great deal of research 
given that these cells are profoundly reduced in AD (Johnston et al., 1979; 
Whitehouse et al., 1982; Coyle et al., 1983; Mann et al., 1984; McGeer et al., 
1984; Lowes-Hummel et al., 1989). In contrast, GABAergic BF neurons have 
been less well characterized within the framework of learning and memory. The 
focus of this dissertation will be on the septohippocampal GABAergic system in 
relation to cognitive changes in aging.  
 
GABA in septohippocampal system and cognition 
It is postulated that the GABAergic and cholinergic systems of the BF 
work together to facilitate hippocampal function. Specifically, the balance 
between these systems has been investigated in association with hippocampal 
learning and memory. Microdialysis experiments showed hippocampal 
extracellular acetylcholine (ACh) increases during hippocampal dependent 
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learning and memory tasks (for example Fadda et al., 1996; Yamamuro et al., 
1996; Fadda et al., 2000; McIntyre et al., 2002).  Drug treatments that enhance 
memory have been shown to increase ACh in the hippocampus, and those that 
impair memory decrease ACh in the hippocampus  (Parent and Baxter, 2004). 
Additionally, GABA released in the BF inhibits the synthesis and release of ACh 
from BF cholinergic afferents in hippocampus. For example, blockade of 
GABA(A) receptors in BF via microinfusions of bicuculine results in increased 
hippocampal  choline acetyl transferase (ChAT) activity, the enzyme that joins 
Acetyl-CoA to choline to make ACh (Kenigsberg et al., 1998). Intraseptal 
infusions of the GABA(A) agonist muscimol impair measures of memory, 
including spatial learning, while decreasing  hippocampal ACh activity (Brioni et 
al., 1990; Durkin, 1992). These data suggest that one way which the BF 
GABAergic system may influence learning and memory is through modulation of 
hippocampal ACh levels that are correlated with learning and memory.  
In addition, some codistributed BF GABAergic neurons directly project to 
the hippocampus, mainly targeting hippocampal GABAergic interneurons, as 
shown in Figure 1. These hippocampal GABAergic interneurons in turn project to 
pyramidal neurons in the hippocampus. Thus, the inhibitory GABAergic 
projection from BF to hippocampus has the collective result of disinhibiting 
pyramidal neurons. Age-related changes in the GABAergic BF system, either 
alone or in concert with alterations in cholinergic neurons, might affect cognitive 
functions supported by the hippocampus/ MTL system. Chapter II will investigate  
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Figure 1. Cholinergic and GABAergic septohippocampal system and 
projection targets. Cholinergic projection neurons in medial septum and the 
diagonal band of Broca (MS/DB) synapse on glutamatergic pyramidal cells in the 
hippocampus. GABAergic projection cells in MS/DB project to GABAergic 
interneurons in the hippocampus, which in turn synapse onto the pyramidal 
cells. Inhibitory signals from MS/DB GABAergic cells results in a net disinhibition 
of pyramidal cells. Additionally, newly discovered glutamatergic projection 
neurons in the MS/DB have been shown to also synapse on pyramidal 
hippocampal cells.  
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age-related changes of GABAergic and cholinergic neurons that comprise the  
septohippocampal projection. 
 
Olfactory function, memory, and age 
Converging evidence suggests that changes in the transduction of odor 
stimuli and/ or the integration of the olfactory information in the piriform or 
entorhinal cortex are affected with age. Indeed, recently a simultaneous two-
choice odor discrimination task was used to test the relationship between odor 
discrimination and spatial learning abilities. In LaSarge et al. (2007), Fischer 344 
(F344) rats characterized on the spatial water maze were segregated into aged-
impaired and aged-unimpaired groups based on their water maze performance 
in relation to young rats. Upon completion of the water maze, rats were tested in 
a simultaneous two-choice odor discrimination task. As shown in Figure 2, rats 
that performed poorly in the water maze (impaired) also demonstrated 
significantly worse performance on odor discrimination problems when 
compared to young and aged-unimpaired rats. In contrast, aged-unimpaired rats 
also performed on par with young in the olfactory discrimination task (LaSarge et 
al., 2007).  
 
Olfactory system and basal forebrain anatomy 
The BF, particularly the horizontal limb of the DB (hDB), provides 
GABAergic and cholinergic projections to the main olfactory bulb and  
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Figure 2*. Scatterplots of individual rat performance, normalized by the 
mean of each group (young and aged). (A.) Spatial learning index on the water 
maze vs. mean trials-to-criterion across all three odor discrimination problems. 
r=0.47, p<0.05 (B.) Spatial learning index on the water maze vs. mean errors-to-
criterion across all three odor discrimination problems. r=0.48, p<0.05. 
*Reprinted with permission from “DEFICITS ACROSS MULTIPLE COGNITIVE 
DOMAINS IN A SUBSET OF AGED FISCHER 344 RATS” by LASARGE, C.L., 
MONTGOMERY, K.S., TUCKER, C., SLATON, G.S., GRIFFITH, W.H., 
SETLOW, B., & BIZON, J.L., 2007. NEUROBIOLOGY OF AGING, 28(6), 928-
936. Copyright 2007 by Elesevier. 
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consequently is involved in the modulation of the olfactory system (Mesulam et 
al., 1983; Zaborszky et al., 1999).The olfactory system refers to interconnected 
structures that are involved in the transduction and processing of odors. 
Included in this system are the main olfactory bulb (MOB), accessory olfactory 
bulb, primary olfactory cortex, and accessory olfactory cortex (for review see 
Shipley et al., 2004). The primary olfactory cortex (including piriform cortex, 
entorhinal cortex, as well as many other structures) is involved in the processing 
and integration of odor information (Shipley et al., 2004). In addition to the BF 
projections to the MOB, there is a high level of interconnectivity between the 
olfactory system and the MTL. Neurons in the MOB and piriform (olfactory) 
cortex project directly to EC, which has reciprocal connections with 
hippocampus (Zald and Pardo, 2000; McNamara et al., 2004; Shipley et al., 
2004). Together this circuitry suggests a basis for a strong relationship between 
olfaction and memory. Furthermore, changes in the integrity of the cholinergic or 
GABAergic BF systems may have consequences that extend to both the MTL 
and olfactory system. 
The main cholinergic projection to the olfactory system arises from 
cholinergic nuclei in the hDB  of the BF  (Shipley et al., 2004). It is estimated that 
10-20% of bulbopetal BF projections from hDB are cholinergic (Semba, 2000). 
Immunohistochemical labeling of acetylcholinesterase (AChE), the enzyme that 
degrades acetylcholine to choline and acetate, indicates that cholinergic neurons 
synapse in all layers of the olfactory bulb, as well as piriform cortex (Wilson et 
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al., 2004). However, ChAT immunohistochemistry revealed no ChAT+ cells in 
MOB (Shipley et al., 2004; Wilson et al., 2004). This expression pattern 
suggests that these AChE+ neurons receive cholinergic input and help break 
down ACh in the MOB, but that ACh is not synthesized in the MOB itself. The 
utilization of ACh from a source outside the MOB suggests a role of the BF in 
odor processing.  
In addition to the cholinergic afferents from hDB to MOB, 30% of this 
projection arises from GABAergic nuclei. GABAergic BF neurons that project to 
MOB are located lateral and caudal to the cholinergic neurons in the hDB 
(Záborszky et al., 1986; Zaborszky et al., 1999; Semba, 2000). The exact layers 
of MOB to which GABAergic neurons in the hDB project have not yet been 
determined. Within the bulb itself there is a large number of GABAergic neurons 
including interneurons (Shipley et al., 2004). This common location of BF 
GABAergic terminals and GABAergic interneurons of MOB may also allow for an 
interaction between the two neuronal populations similar to that in the 
hippocampus, in which the GABAergic BF neurons might synapse onto 
GABAergic interneurons. The inhibition of GABAergic cells would result in a net 
disinhibitory effect on mitral cells, the primary output cells in the MOB.  
 
Cholinergic and GABAergic systems and olfactory learning and memory 
Similar to the septohippocampal system, BF cholinergic and GABAergic 
neurons that project to the olfactory system have been implicated in memory 
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formation for odorants (Sanchez-Andrade et al., 2005). Although the exact 
mechanism remains unknown, it is possible that GABAergic BF projections help 
to disinhibit mitral cells through interaction with presynaptic  GABAergic 
interneurons, while cholinergic projections from BF that synapse on the mitral 
cells facilitate odor memories. This interaction of cholinergic and GABAergic BF 
neurons and their projections to MOB are shown in Figure 3. This theory is 
supported by experiments demonstrating the importance of ACh in MOB for 
olfactory learning and memory. Lesions of hDB, which provides the main source 
of ACh, impair olfactory memory (Wilson et al., 2004). Pharmacology studies 
show that scopolamine, which blocks muscarinic ACh receptors, disrupts 
memory in olfactory tasks including an olfactory delayed match to sample task 
(Fletcher and Wilson, 2002). Additionally, ACh infusion into olfactory bulb 
causes immediate, persistent modulation of olfactory bulb excitability (Wilson et 
al., 2004). Even less is known about the role of GABA in olfactory discrimination 
abilities, although GABA(A) and GABA(B) receptors are found throughout most 
layers of the main olfactory bulb (Shipley et al., 2004). Experiments targeting the 
GABAergic system in olfactory learning tasks could be of great utility to 
determine the role of GABA in odor memory and discrimination abilities. The 
ability of GABA to modulate odor learning will be examined in Chapter III. 
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Figure 3. GABAergic and cholinergic (ACh) projections from horizontal limb of 
the diagonal band of Broca (hDB) to the main olfactory bulb (MOB). 
Cholinergic hDB neurons project to glutamatergic mitral cells (Glu) in the olfactory 
bulb. GABAergic hDB projection neurons synapse on GABAergic interneurons 
(granule cells), that in turn synapse onto mitral cells. GABA release from hDB 
GABAergic neurons inhibit granule cells, resulting in a net disinhibition of the mitral 
cells. Mitral cells receive projections from the olfactory receptor neurons, and are the 
primary output cells of the MOB to the olfactory cortex.   
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CHAPTER II 
INTEGRITY OF CHOLINERGIC AND GABAERGIC BASAL FOREBRAIN 
NEURONS IN AGING 
 
Introduction 
The basal forebrain refers to a boomerang shaped heterogeneous 
population of cells contiguously distributed beginning rostrally in the medial 
septum and extending caudally into the rostral portion of the lateral hypothalamic 
area (Sofroniew et al., 1987; Butcher and Woolf, 2004). Cholinergic and 
GABAergic neurons are co-distributed in these nuclei and comprise the majority 
of corticopetal BF neurons. Cholinergic neurons can be identified by labeling of 
either choline acetyl transferase (ChAT), the enzyme that joins Acetyl-CoA to 
choline to make ACh, or AChE. BF GABAergic neurons are on average two-fold 
more abundant than cholinergic neurons, but only a subset project to cortical 
targets (Rye et al., 1984; Saper, 1984; Kiss et al., 1990; Gritti et al., 1993). The 
BF GABAergic neurons do not form a homogenous population, but instead are 
classified as either interneurons that project  to other BF neurons or projection 
neurons that innervate the hippocampus, olfactory bulb, or other cortical 
structures (Risold, 2004). GABAergic neurons in the rostral BF that project to 
telencephalic regions commonly express parvalbumin (PARV), a calcium binding 
protein that is associated with high cellular metabolism and a high cell firing rate 
(Gaykema and Zaborszky, 1997). Visualization of GABAergic BF neurons is 
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commonly achieved using antibody labeling of either PARV or the enzyme L-
glutamic acid decarboxylase (GAD). GABAergic neurons use GAD to synthesis 
GABA, the main inhibitory neurotransmitter in the brain. In the BF, there are two 
isoforms of the GAD enzyme; GAD67 is found in the GABAergic projection 
neurons and GAD65 is found in the GABAergic interneurons (Castañeda et al., 
2005).  
In AD and the normal aging process, deficient cholinergic indices have 
been linked to reduced number and size of BF cholinergic neurons (Johnston et 
al., 1979; Whitehouse et al., 1982; Coyle et al., 1983; Mann et al., 1984; McGeer 
et al., 1984; Lowes-Hummel et al., 1989). Many studies to date have 
investigated cholinergic neuronal degeneration in aged rats using a number of 
detection methods, counting methodologies, strains, and ages (Gilad et al., 
1987; Koh and Loy, 1988; Fischer, 1989; Altavista et al., 1990; Fischer et al., 
1991; Armstrong et al., 1993; Lee et al., 1994; Smith and Booze, 1995; 
Stemmelin et al., 2000; McQuail et al., 2010). The large number of variables 
differing across studies makes it difficult to draw definitive conclusions as to the 
presence and magnitude of phenotypic and/or degenerative changes in 
cholinergic neurons during aging and, in particular, how such changes relate to 
cognitive dysfunction. For example, many early studies did not have the benefit 
of modern immunohistochemical detection methods and quantitative cell 
counting techniques such as semi-automated quantitative design-based 
stereology. This technique affords accurate estimates of total neuronal number 
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without assumptions regarding size, shape, or orientation of cells. Such 
methodology is critical for obtaining accurate estimates of the number of 
neurons, including those within BF, as age-related changes in size (both 
shrinkage and hypertrophy) of these neurons are well documented (Armstrong 
et al., 1993; Greferath et al., 2000; Veng et al., 2003; Smith et al., 2004).  
It is becoming increasingly clear that corticopetal BF GABAergic neurons 
exert influences on neural transmission and cognitive functions linked to their 
terminal fields (Freund and Antal, 1988; Kiss et al., 1990; Freund and 
Meskenaite, 1992; Pang et al., 2001). GABAergic neurons are positioned to 
influence cortical circuitry, both through their direct input to cortical structures 
and via the interconnected cholinergic and GABAergic neural network within the 
BF (Freund and Antal, 1988; Freund and Meskenaite, 1992). Cholinergic BF 
neurons have been shown to provide extensive local collaterals to GABAergic 
BF interneurons and projection neurons. These GABAergic neurons reciprocally 
synapse on cholinergic neurons to create an interconnected neural system in the 
BF capable of providing feedback (Brauer et al., 1998; Zaborszky and Duque, 
2000; Colom et al., 2005; Gritti et al., 2006). Surprisingly, relatively little is known 
regarding the anatomical integrity of the GABAergic projection neurons in AD 
(for review of existing literature, see McKinney and Jacksonville, 2005). In rats 
(F344), Smith and Booze (1995) reported no age-related loss of non-isoform 
specific GAD immunoreactive neurons. However, a reduction of PARV 
containing neurons has been previously reported in BF of aged rats (Miettinen et 
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al., 1993; Krzywkowski et al., 1995). Parvalbumin is a useful marker for 
identifying BF GABAergic projection neurons, as it is not expressed by 
GABAergic interneurons (Kiss et al., 1990; Gritti et al., 1993; Gritti et al., 2003). 
The functional impact of reduced PARV expression on local and cortical 
circuitry, and specifically how such changes might relate to age-related cognitive 
decline, remains unknown.  
Methodologically sound, unbiased cell counts in the MS and both vertical 
limb of DB (vDB) and hDB are necessary to determine how aging affects 
GABAergic neuronal integrity and number, and if any changes are related to loss 
of cognition. Due to the extensive collaterals between the cholinergic and 
GABAergic BF systems, cholinergic cell counts in the same animals could 
contribute to understanding of how the two systems are affected in conjunction 
during the aging process and if changes are linked to a decline in cognitive 
function. In the present experiment we behaviorally characterized young and 
aged rats in the water maze to determine cognitive ability and subsequently 
performed confocal stereology on immunohistochemically labeled sections in 
order to estimate the number of cholinergic and GABAergic cells in the rostral 
BF. Estimated numbers of cholinergic and GABAergic projection neurons in BF 
were analyzed with regard to chronological age and cognitive status. We 
hypothesized that age-related changes in both cholinergic and GABAergic 
neurons contribute to declining mnemonic abilities at advanced ages. 
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Experimental design   
Subjects 
Young (6 mo; n=6) and aged (22 mo; n=12) male F344 rats, obtained 
from the National Institute of Aging colony, were behaviorally characterized on 
the Morris water maze (LaSarge et al., 2007; Bizon et al., 2009). Aged rats of 22 
mo were used to investigate behavioral and neurobiological changes at 
advanced ages, as F344 rats average age of mortality is 24 - 26 mo (Lipman, 1996; 
Turturro et al., 1999; Harker and Whishaw, 2002; Nadon, 2006). Rats were housed in 
the Psychology Building at Texas A&M University for two weeks prior to the start 
of any behavioral testing. The AALAC- accredited vivarium was maintained at a 
consistent 25 degrees Celsius with a 12:12 hour light/dark cycle (lights on at 
0800 hours). Rats had free access to food and water at all times. All rats in the 
study were screened for health problems including, but not limited to, cataracts, 
jaundice, food and water intake, and tumors. Sentinel rats, housed alongside the 
rats in this study, were routinely screened for a range of pathogens and found to 
be negative. 
 
Morris Water Maze training  
The Morris water maze task is widely used to assess spatial learning 
abilities in rodent models due to its sensitivity to damage to the medial temporal 
lobe (including hippocampus) and BF neurons (Morris, 1984; Sutherland et al., 
1989). The maze consisted of a circular tank (diameter 183 cm, wall height 58 
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cm) painted white and filled with water (27° C) made opaque with the addition of 
nontoxic white tempra paint. The maze was surrounded by black curtains to 
which were affixed large white geometric designs that provided extramaze cues. 
A video camera mounted above the center of the maze was connected to a DVD 
recorder and computer, which were used for data storage and analysis using a 
video tracking system (Water 2020, HVS Image, UK). In the hidden platform task 
a retractable escape platform (diameter = 12 cm, HVS Image, UK) was 
submerged two centimeters below the water’s surface in the southwest quadrant 
of the maze. In the cued platform task a black platform (diameter = 12 cm) that 
protruded 2 cm above the water’s surface was located in a different quadrant on 
each trial.    
 
Hidden platform training 
Rats were trained as described in LaSarge et al. (2007). In brief, rats 
received three training trials a day for eight consecutive days. On each trial, rats 
were placed into the water facing the wall of the maze at one of four equally 
spaced start positions (north, south, east, or west). The start positions were 
varied in a pseudorandom fashion such that all rats started from each of the 
locations the same number of times. Rats were allowed to swim for up to 90 s in 
order to locate the platform before they were guided to it by the experimenter. 
Rats remained on the platform for 30 s, and subsequently were placed in a 
holding cage for a 30 s inter-trial interval. Every sixth trial was a probe trial, in 
  
20 
which the platform was lowered to the bottom of the maze for the first 30 s of the 
trial, after which it was raised to allow the rat to escape.  
 
Visible (Cued) platform training   
Following training on the reference memory task, rats were given a single 
session with six trials of cue training. In this session, rats were trained to escape 
to a visible platform that was moved to a different maze quadrant on each trial. 
Rats were given 90 s to reach the platform and were allowed to remain there 
briefly before a 30 s inter-trial interval.  Visible platform training is not medial 
temporal lobe dependant, but has the same motivational and sensorimotor 
requirements as the hidden platform version allowing detection of deficits 
unrelated to memory that might contribute to performance deficits. 
 
Statistics 
 Water maze data files were created by the Water 2020 software (HVS 
Image, UK). Data were imported to SPSS (v. 16.0) for analysis, and in all 
statistical comparisons described below, p values less than 0.05 were 
considered significant. 
 
Visible (Cued) platform training 
 Pathlengths from visible platform swim trials 2 through 6 were averaged 
for individual rats; the first trial was excluded to control for acclimation to the 
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change from the hidden to the visible platform version of the water maze. 
Individual aged rats’ pathlength averages were examined to confirm that they fell 
within 2 standard deviations of the young mean for inclusion in the larger data 
set. Group pathlength averages were compared using a one-factor ANOVA 
(pathlength average x age group).   
 
Hidden platform training   
Training trial data were averaged into four blocks consisting of the five 
trials preceding each probe trial, and performance was analyzed using 
cumulative search error. To calculate cumulative search error, the rat’s distance 
from the platform location was sampled 10 times/s and these distances were 
averaged into 1 s bins. Cumulative search error is the sum of these 1 s bins 
minus the optimal path from the start location to the platform (Gallagher et al., 
1993). Additional measures of performance (e.g., latency, swim speed) also 
were recorded. Data from interpolated probe trials (i.e. every sixth trial) were 
analyzed using mean search error. This measure was derived by dividing the 
cumulative search error by 30 s (i.e. the probe trial duration). Comparisons 
between age groups on both training trial blocks and probe trials were 
conducted using two-factor repeated measures ANOVAs (age X training trial 
block or probe trial) with Fisher’s LSD post-hoc tests conducted where 
appropriate. 
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In addition to the comparisons described above, a Spatial Learning Index 
(SLI) score was derived for each rat using criteria described in Bizon et al. 
(2009).  The SLI, first established by Gallagher et al. (1993), is calculated by 
weighting and summing mean search error from the interpolated probe trials to 
provide an overall measure of spatial learning ability for each rat. Weights for 
each probe trial were derived by dividing the mean search error in the young 
group on probe trial 1 by the mean search errors on probe trials 2-4. Using data 
from a large F344 study population, the weights assigned to each probe trial 
were: probe trial 2: 1.25; probe trial 3: 1.60; probe trial 4: 1.70 (Bizon et al., 
2009). Lower SLI scores indicate better performance. A one-factor ANOVA and 
Fisher’s LSD post hoc tests were used to assess differences between age 
groups using the SLI measure. 
For group comparisons, aged rats were subgrouped based on SLI scores: 
aged-unimpaired (i.e. those aged rats that performed within the range of young 
rats) and aged-impaired (i.e.  aged rats that performed outside this range). A 
two-factor repeated measures ANOVA (cognitive age group X probe trial) and 
Fisher’s LSD post hoc analyses were used to compare training trial performance 
among these age groups. 
 
Stereological estimates of neuron number   
Tissue preparation  
One week after behavioral training rats were rapidly euthanized with an 
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overdose of pentobarbital and perfused transcardially (0.9% saline followed by 
4% paraformaldehyde).  Brains were removed, postfixed in perfusate (24 hr) and 
cryoprotected in 20% sucrose in 0.1 M phosphate buffer (24 hr).  Brains were 
sectioned through BF on a freezing microtome (coronal plane, 30 μm) and 
adjacent series of sections collected into cold cryoprotectant solution (25% 
glycerin. 25% ethylene glycol, 50% 0.1 M phosphate buffer, pH 7.4) and stored 
(–20oC) until processing. 
 
Immunofluorescence 
Adjacent series of sections were processed for ChAT and GAD/PARV 
immunofluorescence to identify cholinergic and GABAergic BF projection 
neurons, respectively. Sections were rinsed in Tris-buffered saline (TBS; 100 
mM Tris-HCl, 150 mM NaCl, pH 7.5), pre-incubated in blocking solution 
containing 3% normal donkey serum (NDS), 0.3% Triton X-100 in TBS for 1 hr 
and incubated in the blocking solution with the addition of the appropriate 
primary antibodies for 72 hr at 4˚C. Specific antibodies used were: goat anti-
ChAT (Chemicon AB1449, 1:1000), rabbit anti-GAD67 (Bioworld, 1:500), and 
mouse anti-PARV (Sigma, P 3088, 1:500). After primary incubation, sections 
were rinsed in TBS, then incubated in TBS containing 2% NDS and appropriate 
fluorescent secondary antibodies (Alexa 488 donkey anti-rabbit, Alexa 555 
donkey anti-goat, and Alexa 555 donkey anti-mouse; Molecular Probes, 1:300). 
Secondary incubations were performed for 2 h at room temperature in the dark 
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and sections were then rinsed in TBS and mounted onto Superfrost++ slides. 
Following immunohistochemistry, sections were coverslipped with ProLong Gold 
(Invitrogen), sealed with clear fingernail polish, and stored in the dark at 4oC until 
analysis.   
 
Quantitative stereology on a fluorescent confocal microscope (single- and 
multiple-labeling analysis)  
Design-based stereological quantification was implemented on an 
Olympus Fluoview 300 confocal microscope, equipped with the appropriate filter 
sets, using a CCD camera and Stereo Investigator software.  The Stereo 
Investigator software drove an X-, Y-, Z- Ludl motorized stage. Initial analyses 
determined the penetration of each antibody included in an individual experiment 
in order to restrict sampling in the Z-plane to those areas with complete labeling. 
The BF regions of interest were traced at low power magnification (4X), and the 
Stereo Investigator software was programmed to distribute equally-spaced 
sampling fields in the X, Y dimension within the outlined region. The BF regions 
of interest that were sampled, specifically the MS, vDB, and hDB, are shown in 
Figure 4 (as outlined in Paxinos and Watson, 1998). The software drove the 
stage such that sample areas were chosen in a systematic fashion. Neuron 
counting was performed at 40-60X magnification. Section thickness was 
measured at each sampling site. A guard zone of 3 μm at the top and bottom  
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Figure 4. Anatomical regions and septohippocampal neuronal populations 
quantified. Medial septum, vertical Diagonal Band of Broca and horizontal Diagonal 
Band of Broca were traced as illustrated in figures 13-17 in Paxinos and Watson’s 
The Rat Brain Atlas (red outline). 
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was implemented, in which no cells were counted. At each sampling site, Z-
stacks (containing 1 μm Z-slices) of the entire counting frame were acquired 
serially at each wavelength corresponding to the labels of interest. Counting was 
then performed on the acquired Z-stacks allowing colors/labels to be visualized 
individually or simultaneously, aiding in accurate subcellular localization of 
multiple markers in the same cell (for GAD/PARV colocalized tissue). In each 
rat, cell counts were derived from approximately 10-12 sections, spaced at 120 
μm intervals. These 10-12 sections spanned the entire rostral BF area, and were 
used to estimate total cell numbers in the region. The total number of single- or 
double-labeled neurons was estimated by multiplying the sum of each cell type 
counted by the reciprocal of the fraction of the BF nucleus that was sampled 
(i.e., the fraction of histological sections examined and the fraction of the total 
section thickness examined).   
 
Statistical analysis of cell number 
  Estimates of BF neurons were calculated using the number of cells 
counted in the sampling sites and the area in the outlined region of interest for 
each animal. Stereology data files were created by Stereo Investigator 
(MicroBrightField, Wilmington, VT) and imported to SPSS (v. 16.0). In all 
statistical comparisons, p values less than 0.05 were considered significant. 
Total cell estimates of cholinergic neurons were derived from the number of 
ChAT+ neurons counted. In adjacent sections, total estimates of GABAergic 
  
27 
neuron number included: the total number of GAD+ neurons, the total number of 
PARV+ neurons, and the total number of GAD+ neurons that co-express PARV. 
Estimates of GABAergic or cholinergic BF neuron numbers, including cell 
estimates for populations labeled with each GABAergic markers, were compared 
as a function of age and cognitive abilities (i.e. water maze performance) using 
one-factor ANOVAs (cell estimate of phenotypic marker x age or cognitive 
ability). Additionally, individual estimates of GABAergic or cholinergic neurons 
and spatial learning ability were compared using a Pearson r correlation 
(bivariate correlation of SLI scores with estimates of total number of GAD, 
PARV, GAD/PARV, or ChAT cells).    
 
Results 
Cued (visible platform) task 
Cued (visible platform) water maze was performed to control for 
sensorimotor and motivational deficits that might influence the performance of 
rats on the hidden platform water maze task. All aged rats performed visible 
platform training on par with young.  A one-factor ANOVA revealed no 
differences in cued training between age groups (F(1,23)= 0.23, n.s.).  
 
Spatial (hidden platform) trials 
Training trials  
Figure 5A shows the cumulative search error on training trial blocks for 
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Figure 5. Training  (A) and probe trial (B) data from young and aged 
animals during water maze training.  Using both cumulative search 
error on training trials and mean search error on probe trials, all rats did 
learn, as demonstrated by the improvement in performance over the 
course of trials. However, aged rats were impaired as a group compared 
to young in both training and probe trials.  
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young and aged rats. A repeated measures ANOVA (age x training block) 
revealed that, although all rats improved in their search for the platform over the 
course of training (F(3,66) = 39.86, p<0.01), aged rats performed significantly 
worse as a group compared to the young rats across training trial blocks 
(F(1,22) = 7.73, p<0.05 ). The difference between age groups was not 
influenced by their initial abilities in the water maze, since a one-factor ANOVA 
(first training trial x age group) showed that young and aged rats did not differ in 
their search for the platform on the first training trial (F(1,23) = 0.77, n.s.). 
 
Probe trials 
Probe trial performance of young and aged rats confirmed training trial 
data. Figure 5B shows the mean proximity to the platform during the interpolated 
probe trials for young and aged rats. A repeated measures ANOVA (age x probe 
trial) revealed that all rats improved over the course of training (F(3,66) = 12.90, 
p< 0.01), but aged rats performed significantly worse than the young group 
(F(1,22) = 7.71, p<0.05).  
Figure 6A shows individual performance of young and aged rats during 
probe trials, measured by their SLI score. For group comparisons, aged rats 
were subgrouped based on spatial learning performance using a SLI score cut 
off of 280, such that aged rats were classified as “aged-unimpaired” (< 280; n=6) 
or “aged-impaired” (> 280; n=6) (per Bizon et al., 2009). Figure 6B shows mean 
search error during probe trials separated by cognitive age group. Using  
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Figure 6. Spatial Learning Index scores (A) and probe trial performance 
of cognitive age groups (B). (A) Individual rats SLI scores (with higher 
scores indicative of worse performance) are marked by individual points and 
the upper range of young scores is marked by a dashed line. This graph 
demonstrated the individual variability in the aged group such that some 
perform on par with young (Aged unimpaired: AU) while other perform outside 
the range of the young cohort (above the line; Aged impaired: AI) 
demonstrating impairment. (B) Using the cognitive groups determined by the 
SLI scores on the left, the aged rat groups were split and graphed on their 
probe trial performance to show that the AU group did perform on par with the 
young and it was the AI group that was impaired in their performance in the 
water maze.  
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cognitive age group classifications, a repeated measures ANOVA (probe trial x 
cognitive age group) confirmed that all groups learned over the course of 
training (F(3,63) = 13.67, p<0.01), but there was a difference in performance 
between cognitive groups (F(2,21) = 19.36, p<0.01).  Fisher LSD post-hoc 
analyses indicated that the aged-impaired group performed significantly worse 
during probe trials compared to both the young and aged-unimpaired groups 
(p<0.05), but there was no difference in performance between the young and 
aged-unimpaired groups.  
 
Qualitative analysis of GAD and PARV expression in BF neurons 
Figure 7 shows low and high power images of immunolabeling for GAD+, 
PARV+, and colabeled GAD/PARV+ neurons in MS/DB from a representative 
F344 rat. Immunostaining was uniform for all markers throughout the tissue 
independent of age and cognitive status, revealing full penetration of the 
antibodies. In agreement with previous findings, GAD+ and PARV+ neurons 
were codistributed throughout the MS/DB (for example Fischer et al., 1992; Gritti 
et al., 1993; Smith et al., 1993; Krzywkowski et al., 1995; Baskerville et al., 2006; 
Gritti et al., 2006). As seen in Figure 7, immunofluorescence with GAD and 
PARV antibodies resulted in a high degree of colocalization in both young and 
aged tissue (i.e. GAD/PARV+ cells). GAD+ and PARV+ cells ranged in shape 
from oval to polygonal, as previously described (Gritti et al., 2006). 
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Figure 7. Low and high magnification images of GABAergic basal forebrain 
neurons. The medial septum (MS) and Diagonal Band of Broca (vDB) with GAD67 
(488 laser, green), parvalbumin (555 laser, red), and the co-labeling of GAD67 and 
parvalbumin. Low power images, viewed with the 10x/0.36 objective, show the z-
stack collected with a step size of 0.75 µm. High Magnification Images of 
GABAergic Basal Forebrain Neurons inset are shown from vertical limb of the 
Diagonal Band of Broca (vDB) with GAD67, parvalbumin, and the co-labeling of 
GAD67 and parvalbumin. High power images are viewed with a 60x/1.42 oil 
immersion objective, shown as the collapsed z-stack with a step size of 0.25 µm.  
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Stereological estimates of GABAergic neurons 
Chronological age groups 
Qualitative observations revealed no obvious loss of expression of GAD 
or PARV between age groups. Figure 8 shows the mean estimated GAD+, 
PARV+, and GAD/PARV+ cells derived by stereology in young and aged 
groups. The coefficient of error was ≤ 0.06 for all individual estimates. The 
coefficient of error is a number between zero and one that describes the 
accuracy of a stereological estimate, and the estimate is more reliable as the 
coefficient of error approaches zero. Although the aged group tended to have a 
greater number of labeled cells compared to young, one factor ANOVAs  
revealed no significant difference between young and aged rats in stereological 
estimates of GAD+, PARV+, and colabeled GAD/PARV+ cells (GAD+ (F(1,17) =  
2.43, n.s.), PARV+ (F(1,17) =  2.58, n.s.), GAD+/PARV+ (F(1,17) =  2.40, n.s.) ).   
 
Cognitive age groups 
Figure 9 and Table 1 show the mean stereological estimates of GAD+, 
PARV+, and colabeled GAD/PARV+ cell numbers (+/- SE) in young and aged 
rats subgrouped by spatial learning ability. With all GABAergic markers, an 
increase in number of immunoreactive cells was observed in aged rats with 
cognitive deficits compared to both young and aged-unimpaired rats. One-factor 
ANOVAs revealed a significant difference in the number of GAD+, PARV+, and 
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Figure 8. Estimated GAD+ (A), PARV+(B), and colabeled GAD/PARV+ (C) cell 
numbers in rostral basal forebrain for young and aged rats. GAD+ (A), PARV+ (B), 
and GAD/PARV+ colabeled neurons were stereologically estimated in young and aged 
F344 rats. There was no significant difference in cell numbers for any GABAergic 
phenotypic marker between young and aged rats. 
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Figure 9. Estimated GAD+ (A), PARV+ (B), and colableled GAD/PARV+ 
(C) cell numbers in rostral basal forebrain for young, aged-unimpaired, 
and age-impaired rats. Aged rats were split into groups by their performance 
in the water maze and estimated cell numbers were determined using confocal 
stereology. The aged-impaired (AI) rats had an increased number of cells 
positive for GAD (A), PARV (B), and colocalized GAD/PARV cells (C) when 
compared to young or aged-unimpaired (AU) rats. (D) There was no difference 
in the estimated number of ChAT positive cells between cognitive age groups.  
 
 
* 
* 
* 
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GAD/PARV+ cells in the MS/DB between cognitive age groups (GAD: (F(2,17) = 
12.67, p<0.01); PARV: (F(2,17) = 14.03, p<0.01); GAD/PARV: (F(2,17) = 10.35, 
p<0.01)). Fisher LSD post hoc analyses further revealed  a significant increase 
of 32% in the number of GAD+ cells, a 33% increase in number of PARV+ cells, 
and a 33% increase in estimated GAD/PARV+ cells in the aged-impaired rats 
compared to young. Similar increases in cell numbers were seen in aged-
impaired rats for all GABAergic markers when compared to aged-unimpaired 
rats (p<0.01). Post hoc analyses also showed that young and aged-unimpaired 
rats did not differ in their estimated cell number for any phenotypic marker. 
 
Single labeled GAD+ and PARV+ populations 
In young and aged rats, a small number of GAD+ and PARV+ cells did 
not colabel. The GAD+ only and PARV+ only cells were analyzed to determine 
any differences in their number associated with age or cognitive status. GAD+ 
only and PARV+ only cell numbers were determined by subtracting the number 
of co-labeled GAD/PARV+ cells from the GAD+ or PARV+ cells for each 
individual rat (i.e. GAD+ – GAD/PARV+ cells). T-tests (single labeled GAD+ or 
PARV+ cells x age group) confirmed that GAD+ only or PARV+ only cells did not 
differ between age groups  (t(16) = 0.42 and 0.17, respectively; all n.s.). 
Additionally, one-way ANOVAs (GAD+ only or PARV+ only cells x cognitive 
status) revealed that neither GAD+ only (F(2,17) = 0.08, n.s.) nor PARV+ only 
(F(2,17) = 0.19, n.s.) cells differed as a function of cognitive status.  
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Relationship between GABAergic cell number and spatial reference 
memory performance   
Figure 10 shows the relationship between individual water maze 
performance (SLI), and number of GAD+, PARV+, or GAD/PARV+ cells. Person 
correlation coefficients revealed a significant relationship between SLI scores 
and each marker of GABAergic projection neurons in aged rats: GAD+, r = 0.68; 
PARV+, r = 0.76; GAD+/PARV+, r = 0.66; all p’s < 0.05; Table 2). In aged rats, 
worse performance in the water maze was associated with higher GABAergic 
cell numbers Similar relationships between SLI scores and GABAergic cell 
number (GAD+ and GAD/PARV+, but not PARV+) were observed among young 
rats with worse performance in the water maze associated with higher cell 
numbers. These correlations did not reach significance likely in part due to 
insufficient power (n = 6): GAD+, r = 0.71. p = 0.11; PARV+, r = 0.15, p = 0.78; 
GAD+/PARV+, r = 0.80, p = 0.06 (Table 2).  
 
Qualitative analysis of ChAT expression in BF neurons 
 Sections adjacent to those used for estimating GABAergic cell numbers 
were processed for visualization of cholinergic neurons. Figure 11 shows 
representative ChAT+ immunostaining in MS/DB of young and aged tissue. 
ChAT+ cells were large, robustly labeled, and contained a well defined nucleus. 
In agreement with previous reports, ChAT+ cells had a polygonal and fusiform  
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Figure 10. Correlational analysis of Spatial Learning Index Scores and  
estimated cell populations for GAD+ (A), PARV+ (B), and GAD/PARV+ (C) 
immunolabeled cells. Pearson’s correlation coefficient revealed a relationship 
between GAD+, PARV+, and GAD/PARV+ cell numbers and water maze 
performance in aged rats, such that higher cell numbers were correlated with 
worse performance (higher SLI scores).  
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Figure 11. Low and high power images of cholinergic basal forebrain 
neurons in young, aged-unimpaired, and aged-impaired F344 rats.  The 
medial septum (MS) and Diagonal Band of Broca (vDB) are labeled with ChAT 
(555 laser, shown in green). Low power images are viewed with the 10x/0.36 
objective, and shown is the z-stack collected with a step size of 0.75 µm. A 
closer view of  ChAT expression in cholinergic neurons in seen in the lower right 
corner. High power images, viewed with the 60x/1.42 oil immersion objective, 
show the collapsed z-stack with a step size of 0.25 µm.  
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shape (for example Gritti et al., 2006). Relative to GAD+ and PARV+ cells, 
ChAT+ cells were larger in size but smaller in number and less evenly 
distributed throughout BF nuclei (ChAT cells have a tendency to cluster). 
Analysis in the z-plane revealed full penetration of the ChAT antibody in both 
young and aged rats.  
 
Cholinergic neuron number and age 
Figure 12A shows the mean number of ChAT+ cells in young and aged 
rats. Stereological estimates of cell numbers showed that the number of ChAT+ 
neurons in rostral BF did not differ between young and aged rats. The coefficient 
of error was ≤ 0.07. A one-factor ANOVA revealed that the total number of ChAT 
cells in MS/DB was not significantly different between young and aged groups 
(F(1,17)= 0.28, n.s.).  
 
Relationship between spatial reference memory performance and 
cholinergic neuron numbers 
Figure 12B and Table 1 show the mean estimated ChAT+ cell number 
(+/- SE) for cognitive age groups. Analysis of ChAT cells between young, aged-
unimpaired, and aged-impaired groups further confirmed that ChAT+ cell 
numbers remain consistent into advanced ages in F344 rats, regardless of 
cognitive status. A one-factor ANOVA showed no differences in ChAT+ cell 
numbers between young, aged-unimpaired, and aged-impaired groups,  
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Figure 12. Estimated ChAT+ cells in the rostral basal forebrain for rats 
separated by chronological age (A) and cognitive age groups (B), and the 
correlation analysis of estimated ChAT+ immunolabeled cells and water 
maze performance (C). Aged rats were classified as Aged cognitively 
unimpaired (AU) and Age cognitively impaired (AI) by their performance in the 
water maze measured by Spatial Learning Index (SLI) score. Estimated cell 
numbers were determined using confocal stereology. There was no difference in 
the estimated number of ChAT positive cells between rats separated by 
chronological age (A) or cognitive ability (B). (C) Pearson’s correlation coefficient 
revealed that ChAT+ cell numbers were not correlated with water maze 
performance.  
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regardless of water maze performance (F(2,17)= 0.02, n.s).  
Figure 12C shows the relationship between individual rats’ water maze 
performance (SLI) and ChAT+ cell number. Pearson’s correlations coefficient 
revealed that spatial learning performance in the water maze was not correlated 
with ChAT+ cell numbers in young (r = 0.46, p = 0.36) or aged rats (r = -0.02, p 
= 0.96).  
 
Discussion 
 Young and aged F344 rats were characterized in the Morris water maze 
in order to relate BF GABAergic and cholinergic neuron number to memory 
abilities. As previously shown, aged animals performed significantly worse as a 
group in the water maze compared to a young cohort in both training and probe 
trials (Gallagher et al., 1993; Bizon et al., 2009; for review see LaSarge and 
Nicolle, 2009). However, variability in spatial learning performance was 
observed such that some aged F344 rats performed on par with the young 
cohort, whereas others demonstrated impairment by performing outside the 
range of young. These differences in spatial learning performance were not due 
to motoric or motivational deficits, as performance on a cued (visible) version of 
the water maze did not differ between age and cognitive groups.  
 Tissue from young and aged behaviorally characterized animals was 
immunohistochemically labeled for identification of GABAergic (GAD67+ and 
PARV+) or cholinergic (ChAT+) projection neurons in the rostral BF. GAD67 is 
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the isoform of the GAD enzyme necessary to make GABA in GABAergic BF 
projection neurons (in contrast to GAD65 that is expressed by BF interneurons) 
(Castañeda et al., 2005). Expression of the calcium binding protein PARV in BF 
is also primarily restricted to the GABAergic projection neurons (Freund, 1989). 
As expected based on these previous observations (and the fact that these are 
two markers that should define the same population) GAD+ and PARV+ cells 
were highly colocalized throughout the BF areas quantified. Contrary to the 
hypothesis, we observed a marked increase in the number of GABAergic 
projection neurons selectively in aged-impaired rats compared to aged-
unimpaired and young rats. No difference in GABAergic neuron number was 
detected in the aged-unimpaired when compared to young rats. This increase in 
number was detected by both immuno markers independently, as well as when 
the number of neurons co-expressing PARV and GAD67 were evaluated. 
Furthermore, a significant relationship was present between water maze 
performance and GABAergic cell numbers among aged rats, such that higher 
GABAergic BF projection neuron number was related to worse water maze 
performance. This relationship between worse cognition and higher GABAergic 
projection neuron number in BF was unique to the GABAergic neurons. Notably, 
in adjacent sections, cholinergic cell number was not significantly different 
between age or cognitive-age groups, nor was water maze performance 
correlated with cholinergic neuron number.  
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Age-related changes in GABAergic BF neuron number 
 Our data are consistent with previous findings that have described a 
resistance of BF GABAergic neurons to degeneration with advancing age. Using 
stereology, Smith and Booze (1995) estimated the number of non-isoform 
specific GAD+ neurons in BF of young and aged F344 rats using bright field 
microscopy. Although counts of GAD+ cells in this study were restricted to 
caudal BF (not considered in the current report), there was no difference in 
GAD+ cell estimates between young and aged rats. However, these results 
included GAD65+ neurons. If GAD65+ neurons (i.e., interneurons) declined with 
age, the decrease in number would mask any increase of GAD67+ neurons. 
Without use of stereology, Krzywkowski (1995) also reported no age-related 
changes in GABA+ cell counts in the same rostral areas of BF examined here 
(i.e. MS/DB). In the same study, Krzywkowski (1995) did observe an age-related 
reduction of PARV+ cells in MS/DB.  Notably, young rats in the Krzywkowski 
study were 2-3 mo, and a reduction in PARV+ cell number was observed 
between 2 and 8 mo old rats. These data suggest that PARV is downregulated 
across the young adult lifespan and this may not have been detectable given the 
ages used in the current study (i.e. comparisons between 6 mo and 24 mo rats). 
It should be noted that Krzywkowski et al. (1995) also reported an increase in 
PARV+ cells between 15-16 mo and 26-27 mo, a finding supporting the current 
results in which elevated PARV+ cell number was detected in aged-impaired 
rats.   
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Age-related changes in cholinergic BF neuron number 
Neither age nor cognition-associated changes were observed in 
estimates of the number of ChAT+ neurons quantified. The literature is 
inconsistent with respect to cholinergic cell degeneration with age, with some 
studies reporting cholinergic neuron loss and others failing to observe such 
reductions. In agreement with the current findings, several previous studies 
reported no age-related change in the number of cholinergic neurons between 
young and aged F344 rats (Gustilo et al., 1999; Ypsilanti et al., 2008). McQuail 
et al. (2010) also reported ChAT+ neuron number in MS/vDB did not change 
between young and aged F344 x Brown Norway hybrid rats. In contrast, Smith 
and Booze (1995) reported an age-related reduction in ChAT+ neuron number in 
F344 rats, although this study was restricted to caudal BF. Indeed, regional 
differences in cholinergic neurodegeneration may contribute to the inconsistency 
in reported age-related cell loss. Research in non human primates has shown a 
rostro-caudal gradient in the vulnerability of cholinergic neurons to age-related 
neurodegeneration in BF. Little to no loss of cholinergic cells is evident in rostral 
septal nuclei, but a significant age-related decline in cholinergic neuron number 
occurs in the more caudal nucleus (Stroessner-Johnson et al., 1992). Evidence 
of regional differences also has been found in the rat. One study in Sprague 
Dawley rats reported no reduction with age of ChAT+ neuron number in MS but 
a significant loss of these neurons in more caudal nuclei (de Lacalle et al., 
1996). Regionally specific counts across distinct nuclei of the BF in a rostro-
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caudal manner within the same animals would be very useful for reconciling the 
effects of age on cholinergic neuron number.  
Although we found no change in the cholinergic neuron number with 
advancing age or cognitive decline, age-related changes in the cholinergic BF 
system may still contribute to age-related cognitive impairment. For example, 
changes in calcium homoeostasis have been reported in cholinergic neurons of 
rostral BF in aged-impaired F344 rats from the same study population of aged 
rats used in the current study (Murchison et al., 2009). Calcium is important for 
both the pre- and postsynaptic function, including the release of 
neurotransmitters, and a change in calcium homeostasis in cholinergic neurons 
may affect ACh release from the neuron. In addition to calcium dysfunction, 
there is evidence that aging may disrupt ACh signaling at the receptor level. An 
age-related decline in muscarinic ACh receptor function, as evidenced by 
blunted downstream g-protein signaling, has been reported and the degree of 
dysfunction was correlated with water maze performance (Zhang et al., 2007). 
Together with the current finding, these data suggest that although cholinergic 
cell number is stable with age, dysfunctional cholinergic signaling may contribute 
to age-related cognitive decline even in the absence of frank cell loss.  
 
GABAergic and cholinergic BF cell counts in young rats 
Previously estimates of BF GABAergic and cholinergic cells in young and 
aged rats have been derived using a variety of immunohistochemical counting 
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methodologies. Perhaps in part due to the differences in experimental 
procedures, previous stereological estimates of the total number of GABAergic 
and cholinergic cells in young rats have varied significantly. Differences in 
regional distinctions likely also contribute to discrepancies in cell counts between 
studies. There are not clearly defined nuclei in the BF, which leads to varied 
designations of these nuclei in anatomical regions of BF. Our GABAergic cell 
count reflects an increase from the upper range of a previous estimate that used 
roughly the same anatomical boundaries (Gritti et al., 2006: approximately 
23,000 +/- 14,000 for MS/vDB and hDB). While the reasons for this shift 
upwards in total cell estimates is unclear, one possibility relates to progressive 
advances in the specificity of antibodies and/ or visualization of immunostaining. 
For example, GAD counts reported by the Gritti laboratory (1993, 2006) using 
identical parameters and anatomical boundaries increased from 30,000 to 
119,000 across two studies conducted ten years apart. The lab attributed the 
increase to more specific labeling from the GAD antibody. Using roughly the 
same anatomical boundaries (MS, vDB, and hDB), our cholinergic cell count is 
consistent with a previous estimate of approximately 19,000 cholinergic neurons 
in the MS/DB (Miettinen et al., 2002). However, other stereological cholinergic 
cell counts of the same MS/DB region have been much lower (approximately 
6,500 - 8,000) (Gritti et al., 1993; Gritti et al., 2006). Each of these cholinergic 
studies in addition to the current report employed different ChAT antibodies. 
Additionally, different immunohistochemical techniques also may impact cell 
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counts. Gritti et al. (1993, 2006) dehydrated their tissue for GABAergic and 
cholinergic cell counts before coverslipping. Dehydration causes significant 
tissue shrinkage, reducing section thickness by as much as half. In contrast, 
Miettinen et al. (2002) used a water-soluble epoxy resin embedding solution that 
functions similarly to the mounting media used here for fluorescent 
immunolabeling of GABAergic and cholinergic neurons; both minimize shrinkage 
in the three dimensional tissue structure. Miettinen et al. (2002) and the current 
study reported higher cholinergic cell counts compared to studies which used 
dehydration methods. Importantly, given identical parameters used within a 
study, experimental consistency allows for reliable between-group comparisons 
within a given study.   
 
Implications of age-related changes in GABAergic neuron number for 
cognitive impairment 
 The selective increase in BF GABAergic projection neurons in the aged-
impaired animals suggests that an increase in inhibitory signaling from BF to 
hippocampus might contribute to age-related memory loss. Indeed, a strong 
relationship was observed among aged rats such that higher numbers of 
GABAergic neurons were associated with worse memory performance. 
Evidence from pharmacology experiments has shown that increases in 
hippocampal GABA are associated with decreased performance in learning and 
memory. Hippocampal infusion of the GABA(B) agonist baclofen can impair 
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acquisition in water maze as evidenced by a larger search area for the platform 
(Arolfo et al., 1998). Notably, there is converging evidence that some well 
described actions of pharmacological agents targeting the cholinergic system 
may be mediated by GABAergic septohippocampal projections.  
Electrophysiological studies show that infusions of cholinergic antagonists 
atropine and scopolamine into the MS/DB, which also impair learning and 
memory, cause excitation of GABAergic septohippocampal projection neurons 
(Alreja et al., 2000; Wu et al., 2000). These data suggest that memory impairing 
properties of the cholinergic antagonists may be attributed at least in part to 
modulation of GABAergic projection neurons. Increases in GABAergic neuron 
number in BF may provide a means for cognitive impairment through an 
increase of inhibitory signaling to hippocampus in aged rats.  
Age-related alterations in the hippocampal GABAergic system are 
pertinent to interpretation of the increase in GABAergic neuron number in BF 
described here. Age-related changes in hippocampal GABAergic cell number 
and protein levels have been described (Shi et al., 2004; Stanley and Shetty, 
2004; Segovia et al., 2006; Gaviln et al., 2007). Life span studies have shown a 
decrease in GABAergic cells in hippocampus, from adult to middle age, with a 
further decrease from middle age to advanced ages (Vela et al., 2003; Stanley 
and Shetty, 2004; Gaviln et al., 2007). These decreases  in hippocampal 
GABAergic neuron number included interneurons, to which BF GABAergic cells 
project, Interestingly, although the percentage of GABAergic neurons in 
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hippocampus was reduced, there was no age-related reduction in overall neuron 
number, indicating that this population of GABAergic neurons may exhibit a loss 
of phenotype but not actually degenerate (Shi et al., 2004; Stanley and Shetty, 
2004). Despite the significant loss of hippocampal GABAergic neurons that often 
occurs with advancing ages, it has been reported that basal levels of GABA in 
the hippocampus measured via microdialysis remain consistent between 2 mo 
and 25 mo (Segovia et al., 2006). Thus, increases in GABAergic signaling from 
BF may compensate for the loss of hippocampal GABAergic neurons and help 
to maintain GABA levels in hippocampus.  
 
Identification of new GABAergic neurons in aged-impaired rats 
Although there is an increase in GABAergic BF neurons number in aged-
impaired rats, there is no evidence that neurogenesis occurs in the BF (for 
review Riddle and Lichtenwalner, 2007). If the increased GABAergic neuron 
number is not a result of new neurons, another BF neural population must be 
contributing to this increase in GABAergic neuron. Interestingly, many neurons 
in the septohippocampal system have been shown to exhibit multiple 
phenotypes, including both GABAergic and glutamatergic, GABAergic and 
cholinergic, and cholinergic and glutamatergic (Manns et al., 2001; Colom et al., 
2005; Gritti et al., 2006). Retrograde tracers combined with 
immunohistochemistry were used to determine that 25% of septohippocampal 
projection neurons are glutamatergic, but over 45% of these neurons also 
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express another phenotypic marker for either GABAergic or cholinergic cells 
(Colom et al., 2005). Another stereology study reported that over 90% of 
neurons in MS and over 89% in the DB were glutamatergic; this glutamatergic 
population colabeled with 36.0% of MS and 20.6% of DB GABAergic neurons 
and 4.4% of MS and 14.5% of DB cholinergic neurons (Gritti et al., 2006). These 
data suggest that BF neurons have the capacity to express multiple 
neurotransmitters, and make it intriguing to speculate that the increase in 
GABAergic projection neurons  observed in aged-impaired rats may be specific 
to a neuron population that expresses (or did express) another phenotype. Due 
to the morphology and consistent cell number estimates of cholinergic 
septohippocampal neurons, it seems unlikely that the cholinergic system would 
be involved in the elevation of GABAergic markers. However, the smaller and 
more abundant GABAergic neurons do have similarities to the glutamatergic 
neurons in the BF. Glutamatergic neurons that project to the hippocampus are 
an average of 15 µm in diameter, which is similar to GABAergic 
septohippocampal projections neurons (on average 14.5 µm in diameter) 
(Colom et al., 2005). Additionally, glutamate is a precursor to GABA, the 
formulation of which requires GAD enzyme-induced decarboxylation of 
glutamate. Future studies examining the number of neurons with glutamatergic 
phenotypic markers throughout the lifespan and colocalization with GABAergic 
phenotypic markers should be of great value in determining if the age-related 
GABAergic increase is due to neural shift of phenotype. 
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Conclusion 
In conclusion, young and aged rats were trained in the water maze, and 
while a subgroup of aged rats performed on par with young, the other aged rats 
were impaired compared to young. Confocal stereology was used to determine 
GABAergic and cholinergic cell numbers in young and aged rats. GABAergic 
neurons were selectively increased in aged rats with impaired water maze 
performance, compared to young and aged-unimpaired rats. Moreover, water 
maze performance was correlated with GABAergic BF neuron number in aged 
rats, in which rats with worse performance had higher GABAergic neuron 
numbers. Cholinergic cell number remained consistent between young and aged 
rats and was not correlated with water maze performance. Further studies 
focused on determining the cell population in which the GABAergic markers are 
upregulated, as well determining the functionality of the GABAergic BF neurons 
in this aged cognitively impaired group will be useful for understanding the 
functional implications of these findings. Additionally, the upregulation of 
GABAergic septohippocampal projection neurons in aged-impaired rats 
suggests that pharmacologically targeting the GABAergic system may be an 
effective alternative to the traditional AChE therapies to treat age-related 
cognitive deficits and should be further explored. 
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CHAPTER III 
PHARMACOLOGICAL REVERSAL OF AGE-RELATED COGNITIVE DECLINE 
WITH A GABA(B) ANTAGONIST* 
 
Introduction 
Basal forebrain cholinergic and GABAergic projection neurons are well- 
positioned to directly impact mnemonic function in hippocampus and other 
medial temporal lobe structures, the functions of which are sensitive to 
precipitous decline in aging (e.g., explicit/declarative and spatial learning and 
memory; Frotscher and Leranth, 1986; Freund and Antal, 1988; Baxter et al., 
1996; Pang and Nocera, 1999). As such, these transmitter systems are logical 
targets for therapies to improve cognitive capacities in aging. Drugs that 
enhance cholinergic activity (either through direct agonistic actions at cholinergic 
receptors or by increasing ACh availability by inhibiting AChE activity) enhance a 
variety of cognitive functions across species (for review, please see Parent and 
Baxter, 2004) and most currently available treatments for age-related cognitive 
decline are AChE inhibitors (Fischer, 1989; Smith and Booze, 1995; Gibbs, 
1998; Gilmor et al., 1999; Doggrell and Evans, 2003; Jones, 2003; Parent and 
Baxter, 2004).  Indeed, patients with mild cognitive impairment (MCI), or loss of 
cognitive function including memory loss without a pathological disease, that 
 
 
___________                                          _    
*Reprinted with permission from “Blockade of GABA(B) receptors completely reverses 
age-related learning impairment” by LaSarge, C.L., Banuelos, C., Mayse, J.D., & Bizon, 
J.L., 2009. Neuroscience, 164, 941-947. Copyright 2009 by Elsevier. 
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take AChE inhibitors show increased hippocampal activity and improved 
performance on explicit memory tasks, demonstrating that these drugs do offer 
clinical benefit (e.g.,Gron et al., 2006). However, this therapeutic avenue in 
isolation has limitations, as the cognitive enhancing effects of AChE inhibitors in 
aged individuals are transient; after 3 years, MCI patients with and without AChE 
inhibitor treatment are cognitively equivalent (Petersen and Morris, 2005). 
Moreover, this class of drugs only appears effective in improving mild loss of 
cognitive functions and offers little benefit to aged individuals with moderate to 
severe learning and memory deficits (Kaduszkiewicz et al., 2005; Birks and 
Flicker, 2006; Pelosi et al., 2006; Raschetti et al., 2007).  
In humans, olfactory functions are increasingly being recognized as being 
vulnerable to age, and olfactory identification and discrimination deficits have 
been linked to more troubling dysfunction in other types of cognition such as 
declarative memory processes mediated by the medial temporal lobe (Gabrieli, 
1996; Freedman et al., 2002; Eibenstein et al., 2005; Wilson, 2006). In 
agreement with these results, our group recently reported such a relationship in 
aged F344 rats (LaSarge et al., 2007). As observed among humans, 
considerable variability naturally occurs among the aged F344 rat population 
such that some aged rats maintain cognitive abilities on par with young cohorts 
while others develop marked and significant cognitive impairment with 
advancing age (Bizon et al., 2009). We observed that the same sub-population 
of aged F344 rats that demonstrates impaired spatial reference memory in the 
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Morris water maze was also impaired in the ability to discriminate odors despite 
the fact that these rats had comparable odor detection abilities and could 
discriminate among other sensory stimuli as well as young and aged-unimpaired 
cohorts (LaSarge et al., 2007).   
Notably, in our previous study, odor discrimination learning abilities in 
individual aged F344 rats were highly consistent across novel odor 
discrimination pairs.  Aged rats classified as “learning-impaired” eventually 
reached criterion levels of performance on a given discrimination problem, but 
there appeared to be neither savings of prior learning rules nor a practice effect 
across subsequently presented odor pairs. Indeed, these rats were just as 
impaired on their third odor discrimination problem as on their first.   As such, the 
olfactory discrimination task presented itself as particularly well-suited for 
assessing the ability of pharmacological agents to improve age-related cognitive 
impairment.  First, the task is as effective as the Morris water maze for 
identifying learning-impaired rats within the aged F344 study population. 
Second, the reliability of the olfactory discrimination learning deficit in aged rats 
allows for the use of a within-subject experimental design in which performance 
of each subject can be evaluated with and without drug treatment.   
Data from lesion studies in young subjects indicate that coordinated actions of 
cholinergic and GABAergic signaling are critical to many aspects of cognition affected 
by age (Baxter et al., 1995; Pang and Nocera, 1999; Pang et al., 2001; Parent and 
Baxter, 2004; Yoder and Pang, 2005), and therefore drug therapies targeting the 
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GABAergic system may offer novel but complementary treatment avenues for 
dementia. Specifically, antagonists at the GABA(B) receptor appear to be promising 
candidates, as compounds from this drug class reportedly enhance cognitive function 
across a wide range of tasks and species in young subjects (Mondadori et al., 1996a; 
Mondadori et al., 1996b; Flood et al., 1998; Getova and Bowery, 1998; Escher and 
Mittleman, 2004; Froestl et al., 2004; Helm et al., 2005; Berta et al., 2009). For 
example, in young rodents and non-human primates, the most well-studied GABA(B) 
receptor antagonist, SGS742 (CGP36742), improves performance in a two-way active 
avoidance task and spatial reference memory in the eight-arm radial and Morris water 
mazes (Getova and Bowery, 2001; Froestl et al., 2002; Helm et al., 2005; Chan et al., 
2006). In the Helm et al. (2005) study, improved memory was associated with 
decreased hippocampal CREB2 (ATF4) activity, indicating one site of action and 
possible mechanism following systemic administration of this compound (Vernon et al., 
2001; Chen et al., 2003; Helm et al., 2005). The clinical utility of this class of 
pharmaceuticals is further supported by the wide range of effective doses at which 
enhanced learning and memory is observed in young subjects and few side effects 
associated with the efficacious doses (Blake et al., 1993; Mondadori et al., 1996a; 
Mondadori et al., 1996b; Getova and Bowery, 2001; Helm et al., 2005; Chan et al., 
2006; Emson et al., 2007).  Nevertheless, surprisingly few studies have examined 
GABA(B) antagonists as a possible treatment for age-related cognitive dysfunction.  In 
this study, the GABA(B) antagonist CGP55845 was assessed for its ability to improve 
odor discrimination learning deficits in aged F344 rats. We expected that administration 
of CGP55845 prior to testing would result in fewer trials- and errors-to-criterion 
(indicating improved performance) compared to saline vehicle in aged cognitively-
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impaired rats, based on other studies investigating the effects of GABA(B) antagonists 
on cognitive function in both animals and humans (Mondadori et al., 1993; Getova and 
Bowery, 1998; Getova and Bowery, 2001; Froestl et al., 2004; Helm et al., 2005). 
 
Experimental design 
Young adult (6 mo, n=10) and aged (22 mo, n=17) male F344 rats 
obtained from the National Institute on Aging colony (Harlan, IN, USA) were 
individually housed in the AALAC-accredited Psychology Department vivarium at 
Texas A&M University with a regular 12:12h light/dark cycle (lights on 08:00) 
and climate control at 25 °C. Rats were given free access to food and water 
except during discrimination testing, when they were food-restricted to 80% of 
their free-feeding weights. All rats were screened daily for health problems 
including but not limited to cataracts, jaundice, food and water intake, and the 
appearance of tumors. Sentinel rats housed in the same room were further 
screened for a range of pathogens, and all blood work was negative throughout 
testing.  All animal procedures were conducted in accordance with approved 
institutional animal care procedures and NIH guidelines. 
  Olfactory discrimination learning was tested according to LaSarge et al., 
(2007). Briefly, the test apparatus consisted of an opaque plastic box (49 x 33 x 
28 cm) divided by an opaque Plexiglas barrier into holding (16 cm) and test (33 
cm) compartments, the latter of which contained two terra cotta flower pots 
arranged side-by-side against the rear wall. Behavior was scored by an 
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experimenter blind to drug treatment using a video feed to a TV monitor that 
allowed the rats to be viewed through the rear wall of the test compartment. 
  Initially, rats were shaped to dig for a food reward (1/4 of a Froot Loop, 
Kellog’s, Battle Creek, MI) buried at varying depths in the pots, which were filled 
with home cage bedding (wood shavings). Raising the Plexiglas barrier marked 
the start of each trial and rats were considered shaped to dig when they 
successfully obtained the food reward buried 2 cm below the surface of both 
pots in under 2 minutes. 
   For discrimination problems, pots were filled with clean home cage 
bedding and the rims of the pots were scented with two different odorants (e.g., 
rose+ and citrus-). Odorants used were perfume oils obtained from The Bath 
Junkie and The Body Shop and 10 µl of the full strength oil was applied to pots. 
Novel odors were used for each discrimination problem (i.e. each odor was used 
only once).  Only one pot contained the food reward (+), and the odor of the food 
was disguised by crushed Froot Loops sprinkled over the bedding filling both 
pots. The position (left or right) of the rewarded pot was varied pseudo-randomly 
across trials. Criterion performance on each problem consisted of six 
consecutive trials in which the correct (baited) pot was chosen. Rats were 
considered shaped to discriminate after reaching criterion performance on two 
odor problems prior to the onset of pharmacological testing.   
  Pharmacological testing began on a separate day after completion of 
shaping.  Young and aged rats received i.p. injections of one of three doses of 
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the GABA(B) receptor antagonist CGP55845 (0.001, 0.01 or 0.1 mg/kg; Tocris, 
Ballwin, MO) or 0.9% saline vehicle alone (1 ml/kg) 40 min prior to testing. The 
number of trials to reach criterion was used as the measure of performance.  
The order of injections was as follows: CGP55845, saline, CGP55845, saline, 
CGP55845, saline, with the order of presentation of the doses of CGP55845 
randomized across rats and age groups.  Only one dose of CGP55845 or saline 
was given each day and a 48 hour washout period was interposed between 
injections (during which no testing was conducted).  Rats were tested in two 
cohorts; rats in the first cohort were tested using the 0.1 and 0.01 mg/kg doses 
(and saline). A second cohort of animals was tested with these two doses and 
an additional 0.001 mg/kg dose. This dose was added to provide a more 
comprehensive dose response curve after it was clear in the initial cohort that 
both 0.1 mg/kg and 0.01 mg/kg doses significantly improved performance. 
  After completion of discrimination testing, a subset of rats was tested for 
their ability to detect and respond to decreasing concentrations of odorants 
following vehicle (saline) and the highest effective dose of CGP55845 (0.1 
mg/kg).  Significant attrition due to the length of time necessary to complete odor 
discrimination testing and test odor detection abilities with and without drug 
resulted in only a subset of subjects (N=5 young adult; N= 4 aged learning-
unimpaired and N=3 aged learning-impaired) completing this testing. Only 
animals that completed all testing, including the doses of CGP 55845, washout, 
saline, and odor detection assessment with and without drug were included in 
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this latter analysis. For these tests, rats were trained on two new odor 
discrimination problems as described above (one for saline and one for 
CGP5585) using novel full strength odorants paired with mineral oil (unscented 
pot). For both problems, the novel odor was rewarded.  After reaching criterion 
performance on the new problem, rats were assessed for their ability to respond 
to decreasing concentrations of the same odorant (diluted 1:10, 1:100, or 1:1000 
in mineral oil) versus mineral oil alone. Assessment of performance at 
descending dilutions was performed immediately after reaching criterion on the 
initial problem. Rats received 16 trials at each dilution and the percentage of 
correct responses was used to assess performance. Saline and CGP 55845 
odor detection testing were performed on different days with at least a 48 hour 
interval between assessments.  
 
Results 
  In agreement with our previous report (LaSarge et al., 2007), significantly 
greater variance in performance was observed among aged rats compared to 
young adult rats following vehicle injections (Levine’s Test of Equality of 
Variance performed on mean trials to criterion on saline problems: F(1,28)=6.55, 
p<0.05) with some aged rats performing on par with young cohorts (hereon 
referred to as aged-unimpaired rats) and others demonstrating marked and 
consistent impairment across multiple discrimination problems (hereon referred 
to as aged-impaired rats).  As shown in Figure 13, young adult rats (N= 10) 
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averaged 10.15 +/- 3.22 (S.D.) trials-to-criterion on saline problems.  
Performance of each aged-unimpaired rat (N=11) fell no more than one 
standard deviation above young adult performance (mean =8.26 +/- 1.89 S.D.; 
animals under line in Figure 13). All other aged rats were classified as aged-
impaired (mean trials to criterion = 19.35 +/- 4.40 S.D.; N=9; animals above line 
on Figure 13).  
 All rats received odor discrimination sessions following saline and two 
doses of CGP55845 (0.1 mg/kg and 0.01 mg/kg). As shown in Figure 14, 
although aged-impaired rats needed more trials to reach criterion after saline 
compared to young adult and aged-unimpaired rats, after both doses of the 
GABA(B) antagonist, aged-impaired rats performed on par with the other two 
groups. These observations were confirmed using a two-factor repeated 
measures ANOVA (Cognitive Age Group X Drug Condition). The ANOVA 
revealed main effects of Cognitive Age Group (F(2,57)= 7.34, p < .01) and Drug 
Condition (F(2,54)= 3.25, p < .05), as well as an interaction between Cognitive 
Age Group and Drug Condition, such that the drug effect on performance  
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Figure 13. Mean trials to criterion of individual young and 
aged rats across saline odor discrimination sessions. Black 
line indicates the classification of aged subjects into aged-
unimpaired and aged-impaired groups. All aged-impaired rats fell 
outside the young mean + S.D., while all aged-unimpaired rats 
performed within that criterion.  
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Figure 14. Mean (+/- S.D.) odor discrimination performance after 
administration of the GABA(B) antagonist CGP55845 or saline vehicle in 
young, aged-unimpaired, and aged-impaired rats. There was a significant 
Cognitive Age Group by Drug Condition interaction such that treatment with 0.01 
and 0.1 mg/kg of CGP558445 improved trials to criterion specifically in the aged-
impaired group. Black lines indicate means in the subset of rats tested with the 
0.001 mg/kg dose, which as shown was ineffective in reversing the learning deficit in 
the aged-impaired group.  
 
Young 
Aged-unimpaired 
Aged-impaired 
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differed across Cognitive Age Groups (F(4,54)= 5.22, p < .01). To confirm that the 
interaction was a result of the drug improving the performance (trials to criterion) 
of aged-impaired rats, a series of one-factor repeated measures ANOVAs within 
each Cognitive Age Group with Drug Condition as the sole within-subjects factor 
was performed. There was a main effect of drug condition in the aged-impaired 
group (F(2,16)= 11.73, p<0.01) but not the young or aged-unimpaired groups 
(Fs<0.58, n.s.).  Post hoc pair-wise comparisons confirmed that the aged-
impaired group performed significantly better with both the 0.01 and 0.1 mg/kg 
dose of CGP 55845 when compared to their saline control trials (all p's<0.05).  
Given that both doses of CGP55845 initially tested were effective in 
reversing the learning deficit in aged-impaired rats, additional testing was 
performed with a lower dose of CGP55845 (0.001 mg/kg) to better define the 
minimum effective dose of this drug. Only a subset of animals was tested at this 
dose (n=5 young adult; n=3 aged-unimpaired; n=5 aged-impaired). These 
animals received all three doses of CGP55845 and saline in the randomized 
order as described above. A repeated measures ANOVA (Cognitive Age Group 
X Drug Condition) was performed on only those subjects that received all three 
doses of CGP55845 to test efficacy of the lower dose. Although no main effect 
of drug was observed (F(3, 30) = 1.22, n.s.), the ANOVA did reveal a main effect 
of Cognitive Age Group (F(2,10)= 11.96, p <.01) and a significant interaction 
between Cognitive Age Group and Drug Condition (F (6, 30) = 2.41, p =.05).  To 
confirm that the interaction was consistent with the larger dataset and that it 
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resulted from the drug improving the performance (trials to criterion) of aged-
impaired rats, a series of one-factor repeated measures ANOVAs was 
conducted within each Cognitive Age Group with Drug Condition as the within-
subjects factor. There was a main effect of drug condition in the aged-impaired 
group (F(3,12)= 3.80, p<0.05) but not the young or aged-unimpaired groups 
(Fs<0.998, n.s.). Post hoc pair-wise comparisons  showed that even with the 
small group size there was still a significant improvement in performance of 
aged-impaired rats with the 0.01 mg/kg dose of CGP 55845 when compared to 
saline (p<0.05); the additional lower dose of 0.001 mg/kg was not effective.    
 We have previously found no evidence for olfactory detection deficits in 
aged learning-impaired F344 rats (LaSarge et al., 2007).  Nevertheless, it is 
possible that CGP55845 enhanced olfactory discrimination learning in this 
subgroup by enhancing olfactory detection abilities.  Hence, after completion of 
discrimination testing, subsets of rats from each Cognitive Age Group (n=5 
young adult; n=4 aged-unimpaired and n=3 aged-impaired) were tested for their 
ability to detect and respond to decreasing concentrations of odorants following 
vehicle and the highest effective dose of CGP55845 (0.1 mg/kg). As shown in 
Figure 15A and in agreement with the above data, on the discriminations 
performed prior to odor detection testing, a two-way ANOVA of Cognitive Age 
Group and Drug Condition revealed main effects of Cognitive Age Group (F (2, 8) 
= 5.77, p <.01) and Drug Condition (F (1, 8) = 7.18, p <.01), and an interaction 
between Cognitive Age Group and Drug Condition (F (2, 8) = 12.29,  
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Figure 15. Olfactory detection testing with and without GABA(B) antagonist. 
(A.) Mean (+/- S.D.) odor discrimination performance in young adult (open bar), 
aged-unimpaired (solid grey bar), and aged- impaired (hatched grey bar) rats after 
injection with either saline (control condition) or 0.1 mg/kg CGP55845 (highest 
effective dose shown in Fig. 1) on discrimination problems prior to odor detection 
testing. The aged-impaired group performed significantly worse than both young and 
aged-unimpaired under the control condition (saline), an impairment that was once 
again reversed under 0.1mg/kg CGP 55845. (B.) After all rats reached criterion 
performance on the odor discrimination problems with saline or CGP55845, the rats 
were assessed for their ability to detect odors at decreasing dilutions. There were no 
differences between Cognitive Age Groups in their ability to detect an odorant at 
1:10, 1:100, or even a 1:1000 dilution of the full strength odor.  
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p <.01). Fisher’s PLSD post hoc analyses confirmed that aged-impaired rats 
performed significantly worse than young adult and aged-unimpaired rats in 
acquiring the problem after saline (p’s< 0.05 in both cases) but not on the 
problem acquired after CGP55845. Figure 15B shows the percent accuracy on 
the two discrimination problems (saline and 0.1 CGP55845) on which the odor 
predictive of the reward was progressively diluted (1:10, 1:100 and 1:1000 of the 
full strength odor). A repeated measures ANOVA revealed no main effects or 
interactions involving Drug Condition, suggesting that the drug did not influence 
odor detection abilities. In addition, a planned comparison of performance on 
descending dilutions of only the aged learning-impaired rats (the group in which 
performance was selectively enhanced by CGP55845) after saline and 
CGP55845 also revealed no main effects or interaction, including at the 1:1000 
dilution (F (1, 5) = 0.45, n.s.), suggesting that the improved olfactory discrimination 
learning observed following CGP55845 in this study was not likely a result of the 
drug altering gross olfactory abilities.  
 
Discussion 
Results from the current study are the first to demonstrate that acute 
treatment with the GABA(B) antagonist CGP55845 can completely ameliorate 
robust learning discrimination deficits that reliably occur in a subset of aged 
F344 rats. Notably, this enhancement of learning performance was selective to 
aged-impaired rats as performance of young and aged-unimpaired cohorts was 
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not significantly affected by CGP55845 at any dose. Moreover, the reversal of 
learning deficits by CGP55845 in aged-impaired rats did not appear to be a 
result of the drug influencing gross olfactory detection ability, as all cognitive age 
groups performed similarly at a 1000-fold dilution of the odorants used for drug 
testing with or without the presence of the drug.   
 In addition to providing support for the use of this GABA(B) antagonist as 
a treatment for age-related learning and memory impairment, these data also 
demonstrate the utility of the simultaneous two-choice odor discrimination task in 
the F344 aging model for preclinical assessment of pharmacological 
interventions to improve learning deficits in aging.  Reliably, approximately half 
of the aged subjects are cognitively impaired in this naturalistic aging model, 
with the same subset of aged subjects demonstrating marked deficits assessed 
in the Morris water maze and olfactory discrimination tasks (LaSarge et al., 
2007; Bizon et al., 2009). In agreement with our findings, Robitsek et al. (2008) 
recently reported that a subset of aged rats impaired in the water maze task also 
performed poorly in an odor recall task, further implicating a role of hippocampus 
in odor learning. Unlike in the water maze, the ability to alternate vehicle (no 
drug) sessions with drug sessions and to observe a consistent return to baseline 
performance in the absence of drug within individual subjects even after 
numerous (upwards of 10) novel discrimination problems allows for stringent 
interpretation that the drug is responsible for changes in learning performance. 
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Indeed, when using novel odors, there appears to be little to no savings from 
learning of prior odor discrimination problems. 
The relationship between performance on the two tasks (water maze and 
the simultaneous two-choice odor discrimination task) in aged rats does suggest 
that the septohippocampal pathway critical for spatial learning may also be 
involved in the odor discrimination task used here. Previously, Eichenbaum et al. 
(1988) found that lesions of the fimbria fornix, which result in deafferentation of 
both cholinergic and GABAergic projections from BF to hippocampus, impair 
learning in a similar simultaneous two-choice odor discrimination task 
(Eichenbaum et al., 1988; Eichenbaum et al., 1989). A number of studies have 
identified the hippocampus as a common site of action following systemic 
administration of GABA(B) antagonists, through mechanisms such as 
disinhibition of excitatory presynaptic terminals and direct actions on post-
synaptic hippocampal neurons (Kulik et al., 2003).  GABA(B) receptor activation 
in GABAergic pre-synaptic terminals causes a decrease in Ca2+ conductance 
which inhibits neurotransmitter release, such that blockade of these receptors 
has a net effect of enhancing hippocampal signaling. Post-synaptic activation of 
hippocampal  GABA(B) receptors increases K+ conductance and CREB2 
activation, a transcription factor implicated as a regulator of memory suppressor 
genes (White et al., 2000; Bettler et al., 2004; Helm et al., 2005; Emson et al., 
2007). In support of the involvement of such a mechanism in the effects 
observed in the present study, Helm et al. (2005) showed that systemic 
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administration of the GABA(B) antagonist SGS742 both facilitated memory and 
suppressed hippocampal CREB2 activation through its interaction with CRE, 
reducing basal CRE binding in young rats. While involvement of the 
hippocampus is suggested, there is also evidence that lesions of the dorsal 
striatum, and not hippocampus, disrupt simultaneous two-choice odor 
discrimination learning (Jonasson et al., 2004; Broadbent et al., 2007). The use 
of systemic administration allows for the drug to affect performance through 
multiple anatomical areas that, although involved in performance, may not be 
critical for odor learning.  
 The absence of memory facilitation in young subjects in the current study in 
comparison to Helm et al. (2005) could be reflective of the different drugs used 
but is more likely due to differences in task difficulty between the two studies. In 
the current study, young and aged-unimpaired rats performed proficiently in the 
two-choice odor discrimination task, producing very few errors in the absence of 
the drug. Thus, there was very little parametric space in which to observe an 
enhancement of performance in these groups. Notably, there was a modest 
trend toward enhancement of learning in young rats at the lowest dose (which 
was ineffective for aged-impaired rats) and performance in young and aged-
unimpaired rats was numerically worse at the highest dose of the drug tested 
here (0.1 mg/kg) relative to saline performance, suggesting that in young 
subjects too much blockade of GABA(B) receptors may impair performance. 
Together with the Helm study, these data suggest that there may be an optimal 
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level of signaling via the GABA(B) receptor that affords maximally proficient 
cognitive performance in both young and aged subjects.  
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CHAPTER IV 
DISCUSSION AND CONCLUSION 
 
Introduction 
 With the average lifespan of humans increasing each decade, the 
population over the age of 65 years is growing steadily (Xu et al., 2010). This 
increase in the number of individuals at advanced ages has resulted in an 
elevation in the frequency of age-related disorders, with both Alzheimer’s 
disease (AD) and Parkinson’s disease in the top 15 reasons for mortality (Xu et 
al., 2010). Age-related impairment is not an inevitable consequence of the aging 
process. Variability in the population exists in which some humans show decline 
in declarative memory tasks in their fourth decade and others maintain 
performance well into advanced age (Albert, 1993; Small, 2001; Bizon and 
Nicolle, 2006).  
The individual variability inherent to cognitive aging in humans has been 
modeled in the F344 rats. In accordance with previous studies, data presented 
in Chapter II showed that a subpopulation of F344 rats succumbs to cognitive 
decline at advanced ages while other aged rats maintain cognitive function on 
par with young subjects (LaSarge et al., 2007; Bizon et al., 2009).  The variability 
among aged rats observed in this model allows age-related changes in 
neurobiology to be related to not only the chronological aging process but also to 
cognitive aging.  
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It has been suggested that neuroanatomical changes (e.g. cell size, 
number, and phenotypic markers) in BF cholinergic and, to a lesser degree, 
GABAergic systems may contribute to age-related cognitive disorders. Previous 
research on the cognitive decline in AD showed a reduction in ChAT expression 
in AD patients compared to age matched controls (Kuhar, 1976), and loss of 
cholinergic BF neurons in patients with AD, particularly in the nucleus basalis 
(Whitehouse et al., 1982). These findings led Bartus et al. (1982) to propose the 
cholinergic hypothesis, stating that loss of cholinergic function is associated with, 
and possibly causal to, cognitive decline and AD. The cholinergic hypothesis of 
AD has been used to further explain cognitive deficits related to both natural 
aging and disease states. As a result, there has been extensive characterization 
of the cholinergic system over the past 30 years, including age-related changes. 
In contrast, data on the neuroanatomical characteristics of the GABAergic BF 
system in aging is much more limited, and almost absent with respect to age-
related changes associated with cognitive decline.   
 
Interactions of basal forebrain cholinergic-GABAergic systems: 
Implications for cognition 
Elevation in hippocampal ACh levels have been linked to learning and 
memory. Microdialysis experiments showed hippocampal extracellular ACh 
increases during hippocampal dependent learning and memory tasks (for 
example Fadda et al., 1996; Yamamuro et al., 1996; Fadda et al., 2000; 
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McIntyre et al., 2002).  Systemic pharmacological treatments that impair memory 
decrease hippocampal extracellular ACh, and drug treatments that enhance 
memory have been shown to increase ACh in the hippocampus (Parent and 
Baxter, 2004). Additionally, GABA released in the BF inhibits the synthesis and 
release of ACh from BF cholinergic afferents in hippocampus. Intraseptal 
infusions of the GABA(A) agonist muscimol resulted in reduced hippocampal 
ACh activity and also impaired memory (e.g. spatial memory) (Brioni et al., 1990; 
Durkin, 1992). In contrast, blockade of GABA(A) receptors in BF via 
microinfusions of bicuculine results in increased hippocampal  ChAT activity and 
facilitation of hippocampal based learning and memory (Kenigsberg et al., 1998).  
Although there is a plethora of data to support the hypothesis that age 
related alterations in the BF cholinergic system accompany cognitive decline, it 
is equally clear that this projection system is not solely responsible for age-
related memory loss. Fornix transections that disconnect the hippocampus from 
BF produced impaired hippocampal based learning and memory, including in the 
water maze (Morris, 1982). However, selective lesions of either the cholinergic 
or GABAergic BF projection neurons alone did not replicate the learning deficit 
observed following fornix lesions (Baxter et al., 1995; Pang et al., 2001). 
Importantly, coordinated disruption of both cholinergic and GABAergic systems 
in concert did produce significant impairment in spatial learning and memory, 
although notably, combined lesions of cholinergic and GABAergic neurons still 
did not produce the extent of damage in spatial learning and memory induced by 
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fornix transections (Morris, 1982; Pang et al., 2001). Furthermore, learning 
impairments produced by either the muscarinic ACh receptor antagonist 
scopolamine or a GABA(A) receptor agonist muscimol are enhanced by lesions 
of the cholinergic system, suggesting that these compounds are acting on 
GABAergic septohippocampal cells (Pang and Nocera, 1999). Together, these 
data show that the age-related changes in the cholinergic system are not solely 
responsible for deficits that emerge in learning and memory, and suggest that 
GABAergic projection neurons have an equally important role in cognitive 
functions supported by the hippocampus. Furthermore, age-related changes in 
the GABAergic system, in concert with the cholinergic system, might contribute 
to cognitive loss.  
 
Role of GABAergic system in age-related cognitive impairment 
In Chapter II, age-related cognitive impairment was associated with an 
upregulation of GABAergic cells in rostral BF. Aged F344 rats behaviorally 
characterized in the water maze were impaired compared to young, but further 
analysis indicated that only a subset of the aged rats were in fact impaired. 
Through the use of immunofluorescence and confocal stereology, GABAergic 
cells (i.e. cells containing GAD67 and/ or PARV) were visualized and counted in 
young and aged rats. Surprisingly, aged-impaired rats had an elevation 
GABAergic neuron numbers of over 30%, across all markers, compared to both 
young and aged-unimpaired rats. Moreover, higher numbers of GABAergic BF 
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projection neurons were associated with greater memory impairment among 
aged rats, suggesting that changes in the GABAergic septohippocampal system 
contribute to age-related cognitive impairment.  
It is possible that the increased number of GABAergic septohippocampal 
neurons observed in aged-impaired rats may reflect a compensatory mechanism 
initiated by age-related alterations of the hippocampal GABAergic system. 
Previous studies reported a loss of GABAergic hippocampal interneurons with 
age (Shi et al., 2004; Stanley and Shetty, 2004; Gaviln et al., 2007). Although 
decreases in GABAergic hippocampal interneurons have been detected in 
aging, suggesting a decrease in hippocampal GABA levels, a microdialysis 
study showed that aged rats have the same basal levels of GABA in the 
hippocampus as young rats (Segovia et al., 2006). This stability in hippocampal 
GABA levels across ages, even after hippocampal GABAergic interneuron 
degeneration, may indicate the presence of a compensatory mechanism 
whereby additional GABA is released from terminals projecting to hippocampus 
from other regions, such as BF. Moreover, an age-related increase in 
GABAergic neuron number may be one mechanism whereby optimal levels of 
GABA are maintained in hippocampus.  
Changes in the BF GABAergic system can affect hippocampal pyramidal 
cell activation. GABAergic septohippocampal neurons synapse onto 
hippocampal GABAergic interneurons that in turn project to pyramidal cells. 
Thus, GABAergic signaling from BF results in a net disinhibition on hippocampal 
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pyramidal cells. Similarly, cholinergic BF cells release ACh and induce a 
subsequent depolarization of the hippocampal pyramidal cells. This complex 
interaction between cholinergic and GABAergic systems allows the two systems 
to work together to control whether pyramidal cells become de/hyper-polarized. 
If increases in hippocampal GABA results from additional BF afferents that 
synapse on GABAergic interneurons, these septohippocampal neurons could 
facilitate an environment in which less inhibitory signaling from hippocampal 
interneurons prevents hyperpolarization of the hippocampal pyramidal cells. 
However, the disinhibition could create a situation where even blunted ACh 
signaling from BF could lead to the excitation of the pyramidal cells. Additionally, 
due to the loss in hippocampal GABAergic interneurons, there may already be 
less inhibitory signal at the hippocampal pyramidal cells. It is possible that the 
increase in GABAergic phenotypic markers are in BF neurons of another 
phenotype, like newly characterized glutamatergic septohippocampal neurons 
that project to pyramidal cells (see Figure 1) (Huh et al., 2010). If the additional 
GABAergic markers are in BF septohippocampal neurons of another phenotype, 
and those cells are functional (i.e. release GABA), it may lead to an overall 
increase in inhibitory tone in the hippocampus. Furthermore, intrahippocampal 
infusions of GABA agonists have been shown to impair learning and memory, 
and therefore it is likely that release of GABA by septohippocampal cells would 
impede learning and memory processes (for review Izquierdo et al., 1991; Farr 
et al., 2000). Understanding the BF cell population in which the upregulation of 
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GABAergic markers is present in those animals with age-related cognitive 
impairment could help to determine future pharmacological therapies to reverse 
cognitive dysfunction. 
 
Role of cholinergic system in age-related cognitive impairment 
 Although cholinergic BF neurons in adjacent tissue sections remained 
consistent in number between young and aged rats (Chapter II), given other 
findings, it is likely that reduced cholinergic signaling with age may be a 
contributing factor to impaired cognition. Indeed, both nicotinic and muscarinic 
ACh receptors are reportedly vulnerable to age. Uchida et al. (2000) found an 
age-related reduction in nicotinic receptors throughout the brain, and others 
have reported decreased expression and binding of Ach to the M2 subtype of 
muscarinic (Narang, 1995). Furthermore, blunted signaling via muscarinic 
receptors has been observed in aged rats impaired on water maze (Zhang et al., 
2007). Other age-related cellular changes in cholinergic neurons may further 
contribute to attenuated cholinergic signaling in aging. Aged-impaired F344 rats 
from the same study population of behaviorally-characterized F344 rats used 
here have increased calcium cell buffering levels in rostral BF cholinergic cells 
relative to young and aged-unimpaired rats. One interpretation of this increased 
buffering is that it may reflect calcium dysregulation in cholinergic neurons of 
aged-impaired rats. The functional implications of this finding could include 
disrupted ACh signaling from BF to the hippocampal pyramidal cells (Murchison 
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et al., 2009). Disruption of ACh signaling from BF, combined with age-related 
changes in the cholinergic receptors, may reduce ACh signaling in hippocampus 
and facilitate an age-related decrease in cognitive function.  
 
Role of septohippocampal system in olfactory learning 
In Chapter III, a GABA(B) receptor antagonist was shown to reverse 
olfactory learning deficits selectively in aged-impaired rats. These finding have 
clear implications for the GABAergic system in age-related cognitive decline 
which is described in more detail below. On a more fundamental level, these 
data are suggestive of a role for GABAergic systems in olfactory learning. 
Notably, this role is not entirely clear from the data generated in our studies and 
remains a fertile ground for future research. Although the GABA(B) antagonist 
was able to improve odor discrimination performance in aged-impaired rats, 
performance was not significantly altered in age-unimpaired and young rats The 
young rats, however, did have a trend towards enhancement of learning at the 
lowest dose of CGP 55845. Importantly, a floor effect may have prevented the 
detection of drug effects on olfactory discrimination learning in young and aged-
unimpaired rats. In the simultaneous odor discrimination task, criterion was met 
at 6 correct trials in a row. Young and aged-unimpaired rats needed very few 
trials over this criterion to complete the task with saline administration compared 
to the aged-impaired, and the performance of the young and aged-unimpaired 
rats left little room for improvement (averages for trials to criterion were 
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approximately 10 for young, 8 for aged-unimpaired, and 19 for aged-impaired). 
Using a more difficult olfactory task in future experiments help clarify whether 
CGP 55845 or other pharmacological agents targeting the GABAergic system 
can influence learning performance in young subjects.  
Insights regarding the role of GABAergic systems, and specifically basal 
forebrain GABAergic systems in olfactory discrimination learning can be 
garnered from our understanding of neuroanatomical circuitry involved in 
different types of olfactory learning. While the MOB is responsible for the 
transduction of odorants, downstream circuitry implicated in the ability to 
correctly associate odors to reward and to discriminate between two odors is 
distinct, depending on the specific demands of the task (for example 
Eichenbaum et al., 1988; Eichenbaum, 1998; Setlow et al., 2003; Illig, 2005; 
Schoenbaum et al., 2006). Specifically, the neural systems implicated in odor 
learning appear to depend upon whether odors are presented simultaneously or 
in succession (sequential). Successive odor discrimination problems are 
facilitated by fornix and EC lesions and therefore do not appear to be mediated 
by the hippocampus / MTL (Eichenbaum et al., 1988; Otto and Eichenbaum, 
1992). Instead, neural recording during go/no-go odor successive discrimination 
problems show OFC and ventral striatum are involved in this type of cue 
predictive odor learning (Setlow et al., 2003). The two-choice odor discrimination 
learning task used in this dissertation includes simultaneous odor presentation 
(two odors are presented together with only one associated with a reward). 
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Interestingly, other labs have reported impaired performance resulting from 
fornix lesion (as well as lesions of the EC and perirhinal cortex) on a two-choice 
(simultaneously presented) odor discrimination task similar to that used in our 
studies (Eichenbaum et al., 1988; Eichenbaum et al., 1989; Otto and 
Eichenbaum, 1992; Otto and Garruto, 1997; Alvarez et al., 2002). In addition to 
implicating the medial temporal lobe system in this type of odor discrimination 
learning, impairments resulting from fimbria-fornix lesions in Eichenbaum et al. 
(1988) further imply a role for cholinergic and GABAergic septohippocampal 
projections in odor discrimination learning.  
To replicate these findings and explicitly test the necessity of 
septohippocampal projections for performance in our odor discrimination 
learning task, we conducted preliminary experiments in which young rats 
received either a fornix transection, a sham surgery, or remained unsurgered as 
an unoperated control. Based on the results of Eichenbaum et al. (1988), in 
which fornix lesions profoundly impaired simultaneous odor discrimination 
abilities, we expected that fornix lesioned rats would be impaired in our 
simultaneous two-choice odor discrimination task and in the spatial version of 
the Morris water maze task. Unfortunately, technical and animal housing 
problems resulted in almost no useable data from this experiment (although 
there was a trend toward the fornix lesions impairing performance in the water 
maze). The number of fornix lesions in the preliminary study was very low, partly 
due to a high attrition rate associated with the medial coordinates for the lesion. 
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The superior sagittal sinus is anatomically located on the top of the brain, down 
the midline, with vasculature branching out from the sinus. Thus, physical 
variations in animals resulted at times in the lesion causing damage to the 
vasculature and extensive bleeding. Further investigations of odor discrimination 
or spatial learning abilities associated with the fornix may best be completed 
utilizing different lesion techniques to target this region while lowering the 
attrition rate. Possible alternative lesion strategies include an angled insertion of 
the electrode from more lateral coordinates, which may bypass the sinus and its 
vasculature. Additionally, using a knife cut instead of an electrolytic lesion 
may help to produce more consistent damage to the fornix, since some rats in 
the preliminary group could not be included due to incomplete lesions (for 
example Liu et al., 2002; Almaguer-Melian et al., 2006). I am currently consulting 
with Dr. Bizon on replicating these experiments in her new lab at University of 
Florida. 
Age-related changes in the GABAergic system are implicated in both 
aged-related impairment in the water maze (Chapter II) and odor discrimination 
abilities (Chapter III), but it is important to acknowledge and consider that 
cognitive decline in the two tasks may not result solely from dysfunction in the 
septohippocampal pathway.  Even though fornix lesions were reported to impair 
odor discriminations in a simultaneous two-choice odor discrimination task 
similar to that used in Chapter III (Eichenbaum et al., 1988), other data supports 
a related but distinct neural pathway in odor learning, particularly the MOB-
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piriform cortex- EC pathway. Lesions of EC have been reported to impair odor 
discriminations that are presented simultaneously when the task requires 
encoding of relations between odors (as in Chapter III), but not when only 
memory for a single odor is necessary (Bunsey and Eichenbaum, 1993; Otto 
and Garruto, 1997; Wirth et al., 1998). Furthermore, disruption of olfactory ACh 
increases generalization between molecularly similar odors and impairs odor 
perceptual learning (Linster et al., 2001; Fletcher and Wilson, 2002; Wilson et 
al., 2004).  Thus, MOB and piriform cortex may be necessary for single odor 
memory, whereas the EC and hippocampus and their projections from olfactory 
system may be involved in tasks that require multiple pieces of information 
pertaining to odors to be processed simultaneously. It is also possible that the 
septohippocampal projection may facilitate, but are not necessary for odor 
discrimination learning.  
Even if fornix lesions do not produce deficits in odor discrimination 
abilities, the BF may still modulate odor discrimination learning. The relationship 
between spatial water maze performance and odor discrimination abilities, and 
the common impairment in aged animals, implicate decline in neural circuitry 
related to both tasks. Moreover, in same study population of F344 rats, there 
was an age-related increase in BF GABAergic neurons in the MS/DB, which 
includes projection neurons from BF to both hippocampus and MOB. Therefore, 
if the age-related elevation in hDB GABAergic cell number leads to an increase 
in GABA in the MOB, increased inhibitory signaling in MOB may result in odor 
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learning deficits. Moreover, systemic injections of CGP 55845 improved 
performance in aged-impaired rats in the simultaneous odor discrimination task; 
this may have been due to effects on both the olfactory and hippocampal 
systems whereby both odor memories (MOB/ piriform) and discriminations with 
multiple odors (EC-hippocampus) are enhanced. Since the BF modulates both 
the hippocampal and olfactory systems, it is possible that dysfunction in the BF 
may contribute to odor discrimination learning deficits. 
 
Reversal of age-related impairment in olfactory learning with CGP 55845 
The results of the pharmacological study presented in Chapter III utilizing 
CGP 55845, a GABA(B) antagonist, were in agreement with the hypothesis that 
an upregulation of GABAergic signaling is associated with cognitive impairment 
in aged rats. Young and aged rats were tested in an olfactory discrimination 
learning task that has been correlated with performance in the water maze. 
Aged rats cognitively impaired in water maze also demonstrated an increase in 
trials and errors to criterion on odor discrimination problems, whereas young and 
aged-unimpaired rats were not different in their ability to perform these odor 
discriminations (LaSarge et al., 2007). Using the same protocol, aged rats were 
classified as “aged-unimpaired” or “age-impaired” based on their ability to 
perform odor discrimination problems compared to young rats. Rats were then 
tested on the odor discrimination learning task under the influence of different 
doses of CGP 55845. Higher doses of CGP 55845 ameliorated odor 
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discrimination deficits in the age-impaired group, such that age-impaired rats 
performed on par with young and aged-unimpaired rats.  
GABAergic bulbopetal projections from hDB  influence odor memories, 
and indeed, lesions of the hDB produce impair olfactory memory (Wirth et al., 
2000; Wilson et al., 2004; Sanchez-Andrade et al., 2005). Infusion of a GABA 
agonist into MOB prevents odor learning in an avoidance task   (Okutani et al., 
1999).  If the effects of CGP 55845 are indeed specific to aged- impaired rats 
(see discussion under previous section), it could suggest an age-related change 
in sensitivity to the GABA(B) antagonist. Indeed, benzodiazepines that act on 
the GABA(A) system show increased efficacy of the inhibitory response that has 
been related to an age-related increase in the α1 subunit of GABA(A) receptors 
(Vela et al., 2003; Yu et al., 2006). As CGP 55845 injections in the current study 
were systemic, the effects of the drug were not localized to any one brain area. 
The enhanced performance observed selectively among aged-impaired rats 
therefore could be related to actions across multiple brain systems. For 
example, the drug could act on both the septohippocampal and olfactory-specific 
circuitry (although notably, CGP 55845 did not appear to enhance rats’ ability to 
detect odors). Future experiments using intracranial infusions of GABA agonists 
and antagonists into specific brain regions (BF, hippocampus, and main 
olfactory bulb (MOB)) of young and aged rats could help delineate the specific 
critical circuitry on which the GABA(B) antagonist is acting to reverse learning 
deficits in aged-impaired rats.   
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Conclusion 
Age-related cognitive decline occurs in the F344 rats in both spatial 
learning and olfactory discrimination learning. However, it has been established 
that natural variability exists in aged F344 rats, such that a subpopulation of 
aged rats maintain performance in the water maze on par with a young cohort 
while others demonstrate impairment. We show that aged rats impaired in the 
water maze had significantly increased numbers of GABAergic BF projection 
neurons compared to aged-unimpaired and young rats. Furthermore, among 
aged rats, GABAergic BF cell number was correlated with water maze 
performance, with higher cell numbers associated with worse performance. 
Cholinergic cell numbers did not differ between young and aged rats, 
irrespective of water maze performance. These data suggest that changes in the 
BF GABAergic septohippocampal system could contribute to age-related 
cognitive impairment. 
Age-related deficits in F344 rats in a simultaneous two-choice odor 
discrimination task have previously been associated with impairments in the 
water maze. Variability in the aged population was detected, such that again 
some rats performed on par with young while others were impaired. However, 
age-related impairments were ameliorated by administration of the GABA(B) 
antagonist prior to performing in the task. These data suggest a role for the 
GABAergic system in odor discrimination task. Furthermore, combined with the 
age-related increase in GABAergic hDB neurons that project to MOB, 
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upregulation of GABA may be responsible for age-related impairment in 
olfactory learning.  
Further experiments to link changes that occur simultaneously in the 
olfactory system and hippocampus, particularly in the GABAergic system, would 
be of great utility to the aging population. Longitudinal studies determining the 
specific time period in which changes in cognition and GABAergic cell 
upregulation in BF occur would offer insight on the inhibitory role of GABA 
transmission in cognitive impairment. Early detection of age-related cognitive 
disorders could allow for pharmacological intervention in order to halt further 
neuroanatomical changes that may be detrimental to cognition.  
The correlative link between decline in multiple cognitive systems during 
aging is currently in early stages of utilization among the human population; 
olfactory tests such as odorant sticks have been used to detect early possible 
cognitive decline (Kobal et al., 1996; Eibenstein et al., 2005).  However, 
neuroanatomical studies to determine common areas of dysfunction across 
these two systems would allow for a better understanding of the 
neurotransmitters, receptors, and other characteristics involved in cognitive 
impairment, possibly allowing for more treatment options. Additionally, further 
research into the GABAergic system may offer a valid option for combating age-
related cognitive decline. Pharmacological studies are needed to determine the 
brain regions that the GABA(B) drug CGP 55845 is acting upon to reverse 
olfactory discrimination impairments, whether this type of therapeutic approach 
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could be extended to the human population, and if possible low dose 
combination therapy with other drugs (such as AChE inhibitors already in use), 
would offer a more efficacious approach to treating cognitive disorders while 
limiting side effects. 
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